Mechanism-based inactivation of glutamate decarboxylase and aspartate aminotransferase with L-serine-O-sulfate by Ueno, Hiroshi
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
1982
Mechanism-based inactivation of glutamate
decarboxylase and aspartate aminotransferase with
L-serine-O-sulfate
Hiroshi Ueno
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
Part of the Biochemistry Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Ueno, Hiroshi, "Mechanism-based inactivation of glutamate decarboxylase and aspartate aminotransferase with L-serine-O-sulfate "
(1982). Retrospective Theses and Dissertations. 7486.
https://lib.dr.iastate.edu/rtd/7486
INFORMATION TO USERS 
This was produced from a copy of a document sent to us for microfilming. While the 
most advanced technological means to photograph and reproduce this document 
have been used, the quality is heavily dependent upon the quality of the material 
submitted. 
The following explanation of techniques is provided to help you understand 
markings or notations which may appear on this reproduction. 
1.The sign or "target" for pages apparently lacking from the document 
photographed is "Missing Page(s)". If it was possible to obtain the missing 
page(s) or section, they are spliced into the film along with adjacent pages. 
This may have necessitated cutting through an image and duplicating 
adjacent pages to assure you of complete continuity. 
2. When an image on the film is obliterated with a round black mark it is an 
indication that the film inspector noticed either blurred copy because of 
movement during exposure, or duplicate copy. Unless we meant to delete 
copyrighted materials that should not have been filmed, you will find a good 
image of the page in the adjacent frame. If copyrighted materials were 
deleted you will find a target note listing the pages in the adjacent frame. 
3. When a map, drawing or chart, etc., is part of the material being photo­
graphed the photographer has followed a definite method in "sectioning" 
the material. It is customary to begin filming at the upper left hand corner of 
a large sheet and to continue from left to right in equal sections with small 
w I II vv/i i vii again—ccgiiiii itig liiw 
first row and continuing on until complete. 
4. For any illustrations that cannot be reproduced satisfactorily by xerography, 
photographic prints can be purchased at additional cost and tipped into your 
xerographic copy. Requests can be made to our Dissertations Customer 
Services Department. 
5. Some pages in any document may have indistinct print. !n all cases we have 
filmed the best available copy. 
University 
iViicrofilms 
International 
300 N. ZEEB RD., ANN ARBOR, Ml 48106 

8221231 
Ueno, Hiroshi 
MECHANISM-BASED INACTIVATION OF GLUTAMATE DECARBOXYLASE 
AND ASPARTATE AMINOTRANSFERASE WITH L-SERINE-O-SULFATE 
lov/a State University PH.D. 1982 
University 
Microfilms 
I n Î© r n 3.t i 0 n 3.1 300 N. Zeeb Road, Ann Arbor, Ml 48106 

PLEASE NOTE: 
In all cases this material has been filmed in the best possible way from the available copy. 
Problems encountered with this document have been identified here with a check marik V . 
1. Glossy photographs or pages 
2. Colored illustrations, paper or print 
3. Photographs with dark background 
4. Illustrations are poor copy 
5. Pages with black marks, not original copy 
6. Print shows through as there is text on both sides of page 
7. Indistinct, broken or small print on several pages 
8. Print exceeds margin requirements 
9. Tightly bound copy with print lost in spine 
10. Computer printout pages with indistinct print 
11. Page(s) lacking when material received, and not available from school or 
author. 
12. Page(s) seem to be missing in numbering only as text follows. 
13. Two pages numbered . Text follows. 
14. C'jriing and wrinkied pages 
15. Other 
University 
Microti ims 
Internatlorial 

Mechanism-based inactivation of glutamate decarboxylase and 
aspartate aminotransferase with L-serine-O-sulfate 
by 
Hiroshi Ueno 
A Dissertation Submitted to the 
Graduate Faculty in Partial Fulfillment of the 
Requirements for the Degree of 
DOCTOR OF PHILOSOPHY 
Department: Biochemistry and Biophysics 
Major: Biochemistry 
Approved: 
For the Graduate'Cdllege 
Iowa State University 
Âmes, Iowa 
1982 
Signature was redacted for privacy.
Signature was redacted for privacy.
Signature was redacted for privacy.
DEDICATION 
INTRODUCTION 
LITERATURE REVIEW 
METHODS 
RESULTS 
DISCUSSION 
SUMMARY 
BIBLIOGRAPHY 
ACKNOWLEDGEMENTS 
TABLE OF CONTENTS 
Page 
iii 
1 
4 
37 
66 
208 
231 
233 
243 
DEDICATION 
To my parents, 
Fujio & Haruko UENO 
for their life-time support. 
1 
INTRODUCTION 
Enzymes dependent upon the vitamin B^-containing coenzyme pyridoxal 
phosphate (PLP) have been studied extensively during the past three 
decades. Their mechanisms of action are well-understood (Metzler, 1977; 
Walsh, 1979). During recent years, new types of inhibitors have been 
designed for PLP-dependent enzymes. These inhibitors are called 
mechanism-based inhibitors, suicide substrates, enzyme-activated 
irreversible inhibitors, or kcat inactivators. A large number of reviews 
about mechanism-based inactivation have been published (Abeles & Maycock, 
1976; Rando, 1974a, 1975; Bey, 1981; Seiler et al., 1978; Kalman, 1979; 
Sandler, 1980; Walsh, 1978). 
The following criteria outline the characteristics of suicide 
inactivators: (1) The inactivators themselves are relatively unreactive; 
however, they become reactive in the active site of the target enzyme. 
(2) During the inactivation, a normal catalytic process of the enzyme is 
required. (3) Inactivation is irreversible and depends upon the 
concentration of inhibitor and the time. The design of more specific and 
efficient inhibitors has been the primary goal of many researchers. 
PLP-dependent enzymes are known to produce key biological metabolites such 
as amino acids and biogenic amines, which can act as neurotransmitters. 
Abnormal amounts of these metabolites can result from malfunctions of PLP-
dependent enzymes. Drugs designed for specific target enzymes may be able 
to control the abnormal amounts of these metabolites or to block a 
specific metabolic pathway. Possible applications for medical and 
pharmaceutical fields have been explored. For example, suicide inhibitors 
for D-amino acid aminotransferase could be new antibacterial 
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drugs (Soper & Manning, 1978). Inhibition of this enzyme in bacteria is 
lethal. Mechanism-based inactivators for y-aminobutyric acid amino­
transferase may be used as drugs to treat Huntington's chorea. In this 
disease, a low level of Y-aminobutyric acid (GABA) is found in the brain 
(Perry et al., 1973; Bird, 1980; Prusiner, 1981). Specific inhibition of 
GABA-transaminase raises the GABA level into the normal range. 
There are two types of mechanism-based inactivators. The 
g-substituted amino acids can undergo enzyme-catalyzed g-elimination to 
form a reactive intermediate that inactivates the enzyme. The olefinic or 
acetylenic amino acids such as propargylglycine and vinylglycine can be 
modified by the active site residues of the enzymes to form an 
inactivating species. 
In this dissertation, the biochemical action between one mechanismr 
based inhibitor and its target enzymes is described. Bacterial glutamate 
decarboxylase (GAD) and cytosolic aspartate aminotransferase (AAT) of pig 
heart have been used as the target enzymes. The amino acid, L-serine-0-
sulfate is the mechanism-based inactivator. This is an example of the 
first type of inhibitor vAiich has a ^-substituent that can be eliminated. 
Both enzymes contain pyridoxal phosphate in their active sites and their 
properties are well-understood. The three-dimensional structure of AAT is 
now known (Arnone et al., 1982), and the mechanism of inactivation is 
discussed at the molecular level. 
Treatment with base of glutamate decarboxylase inactivated by serine 
sulfate released an interesting compound (Likos & Metzler, 1976). 
Characterization of this compound and of its derivatives was begun by 
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Likos but was not completed (Likos, 1977). Further characterization of 
this compound and proof of the structure are reported here. Experiments 
similar to those with GAD have been conducted with AAT and serine 
sulfate. The reaction products have also been characterized using various 
chromatographic techniques, mass spectroscopy, chemical modification, and 
high resolution nuclear magnetic resonance spectroscopy. 
Puzzling observations by Morino et al. (1974) concerning the reaction 
of AAT with S-chloroalanine have been reproduced with AAT. Total 
characterization of compound released by base and its derivatives has 
allowed us to explain Morino's results as well as the nature of the 
mechanism-based inactivation of GAD and AAT. A new mechanism of the 
inactivation of these two enzymes is proposed. The possible application 
of this mechanism to other PLP enzymes is also discussed. A protein which 
participates in the inactivation of GAD with serine sulfate was found. 
Its isolation and partial characterization are also described. 
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LITERATURE REVIEW 
Glutamate Decarboxylase 
L-Glutamate decarboxylase (GAD) from E. coli (EC 4.1.1.15) catalyzes 
the following reaction (1): 
L-glutamate ^ y-aminobutyric acid + CO2 (1) 
This enzyme was first purified by Shukuya and Schwert (1960a) in a 90% 
homogeneous form. They showed that GAD contained tightly bound pyridoxal 
5'-phosphate (PLP) as a coenzyme and had a molecular weight of 300,000. 
The enzyme had a pH optimum around 3.8, and the Kjjj for glutamate was 8.2 x 
10"4 M. By their preparation, 100 g of wet cells gave 60 mg of homo­
geneous enzyme. Shukuya and Schwert (1960b) also observed that the enzyme 
exhibited a sharp pH-dependent spectral transition centered at pH 5.6. 
The enzyme absorbed light maximally at 420 nm at low pH and at 340 nm at 
high pH. The steepness of the pH transition curve suggested the presence 
of some cooperative interaction between the dissociable groups in the 
enzyme. At least four protons were simultaneously dissociated during 
above transition. The enzyme was active at low pH, and its absorption at 
420 nm was due to the formation of a protonated Schiff base between PLP 
and an s-amino group of a lysine residue (Anderson & Chang, 1965). The 
420 nm form was reduced by sodium borohydride (NaBH^), the reduced form 
exhibiting an absorbance maximum at 330 nm. The 340 nm high pH form was 
resistant to NaBH^ and PLP was released from the protein upon a further 
increase in pH (Anderson & Chang, 1965), The 340 nm species is thought to 
be a geminally substituted form arising by addition of some group X to the 
4* carbon of the Schiff base (O'Leary, 1971; O'Leary & Brummund, 1974). 
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Huntley and Metzler (1967a) reported circular dichroism (CD) studies 
of GAD. A large positive CD was observed at 420 nm, but little CD was 
seen at 340 nm. The 330 nm reduced form was optically active. However, 
addition of solid urea (final concentration 8 M) to the 330 nm form 
eliminated the CD without changing the light absorption. 
Shukuya and Schwert reported anion activation of GAD (1960a). 
Chloride gave the greatest effect of activation of the enzyme followed by 
bromide, sulfate, and phosphate. Acetate inactivated the enzyme. Low 
temperature inactivation was also observed by Shukuya and Schwert (1960c). 
The enzyme was crystallized by adding ammonium sulfate (Strausbauch 
et al., 1967). The crystalline enzyme was used in the study of some 
chemical and physical properties of GAD, such as the molecular weight, 
association-dissociation properties, subunit structure, amino acid 
composition, and amino acid sequence of the active site, and also for 
electron microscopy (Strausbauch & Fischer, 1970a, 1970b; Tikhonenko et 
al., 1968; To, 1971). Tikhonenko et al. (1968) found that the enzyme had 
a hexameric structure and could be disrupted by dilution at low 
temperature. 
Strausbauch and Fischer (1970a) confirmed that the molecular weight 
of the active enzyme was 310,000 and that for the subunit was 50,000. 
There was no evidence for nonidentical subunits. Therefore, bacterial GAD 
15 assumed to have six identical subumCs. The quaternary structure was 
investigated by To using electron microscopy techniques (1971). He found 
the enzyme a hexamer of D3 symmetry in an octahedral arrangement. 
An amino terminal methionyl residue and a Lys-Kis-Thr sequence at 
the carboxyl end were found in GAD (Strausbauch & Fischer, 1970a). Sodium 
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borohydride-treated enzyme was digested with trypsin and the peptide 
containing the active site lysine was shown to be Ser-Ile-Ser-Ala-Ser-
Gly-Kis-Lys*-?he (Strausbauch & Fischer, 19?0bKThe complete sequence 
has not been determined yet. Sukhareva and Tilchonenlco (1972) further 
investigated the association-dissociation behavior of bacterial GAD. They 
found a number of factors which influence the reactions: the temperature, 
pH of the solution, concentration of enzyme protein and coenzyme, and the 
structure of the aqueous phase. Low temperature, high pH, or low 
concentration of enzyme or coenzyme led to dissociation of the enzyme. 
The dissociated enzyme was inactive. 
Dunathan (1966, 1971) proposed a general concept for pyridoxal 
5'-phosphate dependent enzyme chemistry. He stated that for an ct-bond in 
the substrate to be labilized it must be perpendicular to the aromatic 
system of the pyridoxal ring. This stereochemical arrangement causes a 
gain in delocalization energy which aids in the bond breaking process. 
GAD is not the exception. The breaking bond between the a-carboxyl and 
the a-cerbon of substrate is believed Co be perpendicular to the 
conjugated system. This leads us to the important conclusion that the 
ct—proton should not be abstract able during the decarboxylation reaction of 
GAD, Experiments using D2O as a solvent or using a-methylglutamate as a 
substrate supported the above concept (Mandeles et al., 1954; Yamada & 
O'Leary, 1977; Huntley & Hetzler, 1967b, 1963; Sukhareva & Tcrchinsky, 
1966). The incorporation of a single atom of deuterium into the product, 
Y—aminobutyric acid was found when glutamate and GAD were incubated in 
D2O. If the a—proton were abstracted during the decarboxylation 
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reaction, the incorporation of two deuterium atoms into the product would 
be expected (Yamada & O'Leary, 1977). A substrate lacking an a-proton, 
a-methylglutamate was reacted with GAD. Normal decarboxylation was 
observed (Huntley & Metzler, 1967b, 1968; Sukhareva & Torchinsky, 1966). 
The decarboxylation of glutamate and of a-methylglutamate have been 
determined to occur with retention of configuration in D2O (Yamada & 
O'Leary, 1978). Two other PLP-dependent decarboxylases, tyrosine 
decarboxylase (Belleau & Burba, 1960) and Lysine decarboxylase (Leistner & 
Spenser, 1975) also showed retention of configuration. 
The decarboxylation product of GAS with L-glutasata is 
Y-aminobutyrate(GABA), an important inhibitory neurotransmitter. Recently 
Ebadi (1981) reviewed the significant role of pyridoxal phosphate in 
central nerve system. An accompanying critique was written by Metzler 
(1981). 
GAD has been isolated from other sources than bacteria. Roberts 
group purified mouse brain GAD in homogeneous form (Wu et al., 1973). 
Maitre et al. (1978) purified human and rat brain GAD. Haber et al. 
(1970) isolated the enzyme from mouse kidney. Some differences have been 
seen between the mammalian and bacterial enzymes. Distinguishing 
differences were in the molecular weight, N-tenainal amino acid residues, 
pH optimum, and the number of subunits. The molecular weight for the 
mammalian enzyme was about 140,000. It is a dimer, and its pH optimum is 
around neutrality. The N-terminal amino acid residues were alanine for 
the human and rat enzymes (Maitre et al., 1978). The mouse brain enzyme 
was inhibited by Cl~ (Susz et al., 1966). The enzyme isolated from 
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crustacean axons showed an activation by K"*", but did not show any effect 
of anions (Molinoff & Kravitz, 1969). Haber et al. (1970) reported that 
the properties of GAD from mouse kidney were somehow similar to those of 
bacterial GAD. 
The stereospecificty of the rat brain GAD during the decarboxylation 
was studied by Bouclier et al. (1979). Like the bacterial enzyme, rat GAD 
catalyzed the reaction of L-glutamate with retention of configuration. 
Cytosolic Aspartate Aminotransferase of Pig Heart 
Aspartate aminotransferase (AAT) (EC. 2.6.1.1) catalyzes the 
following reaction (2): 
L-aspartate + a-ketoglutarate ^  oxaloacetate + L-glutamate (2) 
Highly purified enzymes have been isolated from various sources: a) pig 
heart (Jenkins & D'Ari, 1966; Martinez-Carrion et al., 1967; Michuda & 
Martinez-Carrion, 1969; Morino et al., 1977; Scardi et al., 1963); beef 
liver (Morino et al., 1963; Wada & Snell, 1962); c) chicken heart 
(Bertland & Kaplan, 1968, 1970; Gehring et al., 1977a; Sonderegger et al., 
1977); d) rat heart (Morino et al., 1964); e) human heart (Teranishi et 
al., 1978); f) chicken liver (Schrawder & Martinez-Carrion, 1973; g) beef 
kidney (Scandurra & Cannella, 1972); h) Escherichia coli (Mavrides & Orr, 
1974, 1975). 
AAT exists as two isoenzymes; cytosolic and mitochondrial (Boyd, 
1961; Katunuma et al., 1962). In 1958, the first pure cytosolic enzyme 
was reported by Jenkins et al. and by Lis. The cytosolic enzyme is 
cat ionic and the mitochondrial enzyme is anionic. The former isoenzyme 
has an isoelectric point of about 5.0 and the latter of about 6.8. Later, 
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subforms of AAT, a, B, and Y, were found and were separated by gel 
electrophoresis (Martinez-Carrion et al., 1965, 1967). Their physical 
properties (molecular weight, amino acid sequence) are similar; however, 
the activity and charges are different. The most cationic a form is the 
most active form. The 3 subform is half active, and Y subform is the 
least active and cationic. 
The a subform of cytosolic AAT from pig heart has been studied most 
extensively. The enzyme is a dimer having a molecular weight of 46,344 
per subunit. Each subunit contains one molecule of the coenzyme pyridoxal 
phosphate at the active site. It is linked as a Schiff base with the 
e-amino group of Lys-258. The primary structure of the cytosolic 
isoenzyme was reported independently by Ovchinnikov et al. (1973) and 
Doonan et al. (1975). The sequence of the cytosolic isoenzyme from 
chicken heart has been reported also (Shlyapnikov et al., 1979). 
Recently, the mitochondrial isoenzyme has been completely sequenced by 
Wada and associates (Kagamiyama et al., 1980a, 1980b; Sakakibara et al., 
1980). 
Cytosolic AAT has 412 amino acid residues râile the mitochondrial AAT 
has 11 residues less. A comparison between these two isoenzymes based 
upon primary structure has been made (Kagamiyama et al., 1980b). There is 
a 48% sequence homology (equivalent to 196 positions) with minimum average 
base change per codon of DNA of 0.72. The substitutions of amino acid 
residues at 116 positions are all explained by single base changes in the 
codons. This suggests the evolution of two isoenzymes from a common 
ancestral gene. As is indicated by the appearance of immunocrossover 
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between these two isoenzymes, most of the homologous regions in the 
sequence are located in the interior of the molecules, ^ereas the parts 
with dissimilar sequences occupy the surfaces of these isoenzymes 
(Kagamiyama et al., 1980b). 
Active site sequences of other vitamin Bg dependent enzymes have been 
reported: alanine aminotransferase from pig heart (Tanase et al., 1979); 
tryptophanase decarboxylase from E. coli (Kagamiyama et al., 1970); 
arginine decarboxylase (Boeker et al., 1971); lysine decarboxylase (Sabo & 
Fischer, 1974); glutamate decarboxylase from E. coli (Strausbauch & 
Fischer, 1970b). Also, D-amino acid transaminase from Bacillus sphaericus 
has been sequencing (private communication with Dr. James M. Manning, The 
Rockefeller University, New York). 
The common sequence [Ser-X-X-Lys*-] is found at the active sites of 
all of these enzymes. In the case of AAT, Ser-255 binds to the phosphate 
group of the coenzyme (Arnone et al., 1982). Thus, it is likely that the 
common serine residue acts the same way in the other PLP enzymes. 
AAT from various sources has been crystallized: cytosolic isozyme 
from pig heart (Wada & Morino, 1964; Arnone et al., 1977); from beef heart 
(Wada & Morino, 1964); from beef liver (Morino et al., 1963); from chicken 
heart (Bertland & Kaplan, 1968; Borisov et al., 1978); mitochondrial 
isozyme from chicken heart (Gehring et al., 1977a). Single crystals 
suitable for X-ray crystallographic studies have been grown from solutions 
of polyethylene glycol (Arnone et al., 1977, Metz 1er et al., 1979) as 
described by McPherson (1976). Several groups are currently studying 
X-ray crystallography of AAT (Arnone et al., 1977, 1982; Gehring et al.. 
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1977a; Ford et al., 1980; Borisov et al., 1978, 1980). 
Crystals of cAAT belong to the space group P2i2i2i with unit cell 
dimensions a = 125.1 A", b = 130.8 A°, and c = 55.7 A° (Arnone et al., 
1977). Both cytosolic and mitochondrial isoenzymes have extremely similar 
structure (Ford et al., 1980; Arnone et al., 1982). There are three 
distinct parts in common: a large central domain constructed from 
residues 75-300, a smaller peripheral domain composed of residues from the 
COOH-terminal and NH^-terminal peptides, and a linker region between the 
domains. The coenzyme is bound in the active site by residues from the 
large domain. The coenzyme phosphate group is in contact with side chains 
of Arg-266, Ser-255, Ser-257, Thr-109, Tyr-70* (* indicates the residue 
from other subunit), and the NH2-terminal end of the 108-123 helix. 
Besides the above residues and Lys-258, the coenzyme ring interacts with 
Ala-224, Tyr-225, and Asp-222. The negatively charged carboxylate group 
of Asp-222 neutralizes the positive charge on the ring nitrogen, and 
Tyr-225 interacts with the 3-hydroxyl group and with the internal aldimine 
NH^ group. Difference electron density studies show that the guanidium 
groups of Arg-386 and Arg-292* interact with the carboxyl groups of the 
substrates ( ot-methylaspartate or o^-ketoglutarate) . 
As predicted by Karpeisky and Ivanov (1966), rotation (by about 30°) 
of the coenzyme ring when the a-methylaspartate-aldimine complex was 
formed has been demonstrated by difference electron density studies. 
The 3.5 A° difference electron density map of the 3 subform versus 
the ot subform showed that one subunit of B subform contained a modified 
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coenzyme and the other subunit appeared to be unaltered (Arnone et al, 
1982). The modification of one subunit supported the observation that 
the 3 form is half as active as the a subform. A dicarboxylic acid-like 
inhibitor is assumed to cause the modification found in the a subform 
(Metz 1er et al., 1981). 
Crystals of AAT have also been studied by spectroscopic methods. 
Light spectra of crystals of enzymes, enzyme-substrate or enzyme-inhibitor 
complexes have been reported by various groups (Metzler et al., 1978, 
1979; Eichele et al., 1978, 1979; Makarov et al., 1981). 
As in solution, the two principal absorption bands, at 430 nm and 363 
nm, are in a pH-dependent equilibrium. The spectra of the crystals of pig 
heart cytosolic AAT were measured with the light beam of the 
spectrophotometer parallel to the b-axis of the orthorhombic crystals. The 
plane of polarization of the light used for the measurement is parallel to 
either the a or the c axis. The polarization ratio, the ratio of 
absorbance with the plane of polarization parallel to the c-axis 
(c-polarization) to that in the a-polarization, were measured. 
Surprisingly, large changes in polarization ratios were obtained from the 
spectra of a-methylaspartate or other substrate-enzyme crystalline 
complexes. Rotation of the coenzyme ring in the complex compared to 
native is suggested strongly by these experiments (Metzler et al., 1978). 
Mechanism-Based Inactivation of Glutamate Decarboxylase 
Bacterial glutamate decarboxylase (GAD) is inhibited by various 
substrate analogs, such as a-ketoglutarate, glutarate, a-methylglutarate 
(Lupo & Halpern, 1970), L-isoglutamine, aliphatic dicarboxylic acids 
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(Fonda, 1972a, 1972b), tricarboxylic acid cycle intermediates (Gerig & 
Kwock, 1979), or bromopyruvate (Fonda & DeGrella, 1974). The above 
inhibitors act on GAD competitively with respect to glutamate. 
Jung et al. (1978) showed that bacterial GAD was irreversibly 
inactivated by (R)-(-)4-aminohex-5-ynoic acid. It has been known that 
4-aminohex-5-ynoic acid is a mechanism-based inactivator. It irreversibly 
inhibits both bacterial and mammalian ^ -aminobutyric acid transaminases 
(Jung & Metcalf, 1975; Jung et al., 1977; Bouclier et al., 1979). 
The inhibition of bacterial GAD was specifically caused by the 
(R)-iscmar, but not the (S)-isonier of 4-amir.ohex-5-ynoic acid. Jung et 
al. (1978) suggested that the reaction mechanism involved the abstraction 
of an a-proton from the substrate (Scheme I). Upon addition of 4-amino-
hex-5-ynoic acid, a decrease of the absorption of the native enzyme at 415 
nm and an increase of absorption at 330 nm were observed. Radioactively 
labelled substrate was incorporated, one molecule of substrate apparently 
going into each pyridoxal phosphate binding site. The actual inactivated 
form was believed to be either a conjugated aliéné (Ij) or a ketimine with 
ct-acstylenic group (If). The structure of the Inactivated form has not 
beer, determined yet. 
Interesting results came from studies of mammalian GAD with 
4-aminohex-5-ynoic acid (Bouclier et al., 1979). The mammalian enzyme 
showed a pattern of inactivation similar to that of the bacterial enzyme. 
It was specifically inactivated by the (S)-isomer, but not by the 
(R)-isomer. It appeared that no conversion from (S) to (R) occurred 
during the inactivation. The mammalian enzyme also showed an abstraction 
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of the a-proton from the inhibitor. The stereochemistry of the inhibitors 
is of interest. The a-proton of the (R)-isomer of 4-amino-
hex-5-ynoic acid and the a-carboxyl group of L-glutamate presumably had 
the same orientation. Thus, the stereospecificity of bacterial GAD 
against L-glutamate and (R)-4-aminohex-5-ynoic acid were the same in 
agreement with Dunathan's general hypothesis (1971). However, mammalian 
GAD catalyzed decarboxylation of L-glutamate and deprotonation of 
(S)-4-aminohex-5-ynoic acid. The a-carboxyl group of L-glutamate and the 
a-proton removed from (S)-4-aminohex-5-ynoic acid did not have the same 
orientation. One must ask why the mammalian enzyme catalyzed the 
elimination of the a-proton from the (S)-isomer. One explanation given by 
Bouclier et al. (1979) was that mammalian GAD, like an amino­
transferase, is capable of abstracting an a-hydrogen from L-glutamate or 
form the corresponding position in the (S)-isomer of the inhibitor. 
Other possible mechanism-based inhibitors for GAD were listed in the 
review by Jung et al. (1980). However, detailed chemistry has not been 
published yet. 
In 1971, Sukhareva and Braunshtein reported that bacterial GAD was 
inactivated by L-serine-O-sulfate. Later, Likos & Metzler showed that 
L-serine-O-sulfate was a mechanism based inhibitor for bacterial GAD 
(Likos & Metzler, 1976; Likos, 1977). The enzyme showed an absorption 
change from 420 nm to 335 nm upon addition of serine sulfate. A yellow 
low molecular weight compound was released when the 335 nm form was 
treated with alkali at pH 11. The yellow product was neither pyridoxal 
phosphate nor pyridoxamine phosphate. The identity of the yellow product 
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remained unclear. Likos and Metzler also reported that GAD was 
inactivated with 3-chloroalanine in a manner similar to that by serine 
sulfate. Base treatment of the B-chloroalanine inactivated enzyme gave 
the same yellow product. The results suggested that the enzyme catalyzed 
the B-elimination reaction with either serine sulfate or 3-chloro-
alanine and that the inactivation occurred after the B-elimination step. 
The mechanism that is usually proposed for the mechanism-based 
inactivation of glutamate decarboxylase with serine sulfate is shown in 
Scheme II. In step b, the abstraction of the Q-hydrogen atom of a 
substrate occurs. The e-amino group of Lys-258 might function as a base 
participating in the abstraction of the a-hydrogen atom. In step c, the 
^-elimination occurs to form a highly reactive (%-aminoacrylate Schiff base 
intermediate. Then, the s-amino group of Lys attacks the 3-position of 
the substrate to form a covalent linkage. Both serine sulfate and 
S-chloroalanine are known as mechanism-based inactivators for aspartate 
aminotransferase (see next section). However, the mechanism shown in 
Scheme II does not explain the formation of compound 2. 
Mechanism-Based Inactivation of Cytosolic Aspartate Aminotransferase 
Cytosolic aspartate aminotransferase (cAAT) is irreversibly 
inactivated by various mechanism-based inhibitors such as L-serine-0-
sulfate, 3-haloalaninesJ vinylglycine, 3-methyleneaspartate, a-amino-
Y-methoxybutenoate, or propargylglycine (Scheme III). 
Inactivation of cAAT by serine sulfate was first reported by John & 
Fasella (1969). Incubation of cAAT with serine sulfate at pH 6.5 releases 
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equimolar amounts of puruvate, sulfate, and ammonia. Three reactions were 
found to compete: transamination, ^-elimination, and inactivation. The 
enzyme was practically inactivated during the first few min. After one 
hour, 99% of the catalytic activity was lost. The g-elimination occurred 
with = 70 mM and k^at ~ 12 s"^. A broad spectral band at 340-360 nm 
was observed for the inactivated enzyme. Using uniformly labelled [^^C] 
serine sulfate, it was shown that a three-carbon residue from the 
inhibitor became stably bound to the protein. Later John et al.(1973) 
isolated the labeled peptide. The peptide was prepared by digesting the 
inactivated enzyme with thermolysin, by treating with iodoacetate, and by 
successive chromatography on Sephadex G-25, SP-Sephadex, and paper 
(overall yield, 60%). The amino acid sequence of the isolated peptide was 
reported as Phe-Ser-(carboxymethylcysteine, Gly)-Asn. The peptide was not 
susceptible to Edman degradation, except for the first two NH2-terminal 
residues, Phe-Ser. The COOH-terminal position contained asparagine. 
Both cytosolic and mitochondrial AAT undergo irreversible 
inactivation during an ot, g-elimination reaction with 3-chloro-L-alanine 
(Morino & Okamoto, 1972; Morino et al., 1974). During the inactivation, 
many molecules of pyruvate, Cl~, and NH4"'' are formed for every molecule of 
enzyme inactivated. Over 95% of the enzyme is inactivated within 2 min. 
A rate enhancement by formate ion was found during the inactivation. In 
the presence of 3.2 M formate at pH 7.8, the normal absorption band of the 
enzyme at 362 nm shifted to 345 nm. Also, the pK value of the native 
enzyme was increased from 6.3 to 7.3 by the formate. 
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Upon addition of &-chloroalanine in the presence of 3.2 M formate, the 345 
nm peak disappeared and a new peak corresponding to the inactivated form 
of the enzyme appeared at 333 nm. Reduction of the 333 nm form with 
borohydride gave a band at 325 nm. When radioactive chloroalanine was 
used it was shown that this 325 nm form contained a stably bound 3-carbon 
residue. Enzymatic digestion of this 325 nm form gave a peptide fragment 
containing both the labeled 3-carbon residue and the pyridoxal phosphate 
coenzyme. The labeled Lys-258 was identified from peptide studies with 
both cytosolic and mitochondrial AATs inactivated by &-chloroalanine 
(Morino & Okamoto, 1973; Morino & Tanase, 1978). Tryptic hydrolysis of 
both isoenzymes gave 25 residue fragments. Further digestion with 
chymotrypsin gave Ser-Lys*-Asn-Phe and Ala-Lys*-Asn-Met from cytosolic and 
mitochondrial AATs, respectively (Lys* = modified Lys). Interestingly, 
these modified peptides from tryptic and chymotryptic digestion displayed 
a positive circular dichroism (CD). The corresponding peptide fragments 
from native enzyme treated with borohydride did not give any CD. 
Similar inactivation by S-chloroalanine was observed with alanine 
transaminase (Golichowski & Jenkins, 1978; Morino et al., 1979). In this 
case, a negative CD was observed for the inactivated enzyme. The spectral 
change observed during the inactivation was similar to that with AAT. The 
band at 427 nm disappeared and an inactivated form absorbing around 335 nm 
appeared. Upon longer incubation (over 6 h), a 435 nm band appeared, and 
the intensity of 335 nm decreased greatly. 
Morino et al. (1974) made another interesting observation concerning 
the reaction of cAAT with 3-chloroalanine. In the presence of 3 M 
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formate, the 333 nm form was converted to a form absorbing at 455 nm over 
a period of 20 h. The structure of this form was completely unclear. 
Removal of formate by dialysis produced a drastic change in the spectrum, 
giving rise to three absorption bands at 333, 375, and 420 nm. This 
spectral change was reversible. Addition of formate to this solution gave 
back the 455 nm band. This observation was interpreted as indicating that 
formate was bound to a discrete subsite within the active site which 
normally binds the distal carboxyl group of a natural dicarboxylic acid 
substrate. 
Another surprising observation made by Morino et al. (1974), came 
from borohydride reduction experiments. After the reduction, the 333 nm 
form remained at the same position; however, the 455 nm band shifted to 
365 nm. This 365 nm form released the radioactive label and chromophore 
when treated with 7 M guanidine HCl after borohydride reduction. Before 
denaturation, the radioactive label and chromophore were tied to the 
protein. However, over 80% of the radioactivity was found in the 
supernatant when the 20 h, 455 nm, incubation product, was reduced and 
denatured. The authors left the chemical nature of the 455 and 365 nm 
species uncertain. A similar spectral change was reported for alanine 
transaminase during longer incubations with g-chloroalanine by Golichowski 
and Jenkins (1978). A new band at 435 nm appeared over a period of 6 h. 
Again, the chemical nature of the compound giving rise to this band 
remained uncertain. 
Cytosolic aspartate aminotransferase is also inactivated by other 
3-haloalanines. Morino and Okamoto (1970) reported the inactivation 
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reaction with &-bromoalanine. Silverman and Abeles described the reaction 
of cAAT with &-polyhaloalanine (1976). Enzyme was irreversibly 
inactivated by 3-fluoroalanine and 0-chloroalanine., but not by g, g-di-
chloroalanine or g, g, &-trifluoroalanine. Dichloroalanine did not bind 
to the enzyme, however. Trifluoroalanine bound, but did not inactivate. 
The authors suggested that the slow rate of ce-proton removal from 
trifluoroalanine by cAAT might be the reason that it was not an effective 
inactivator. The proposed mechanism of inactivation of AAT with 
grhaloalanine or serine sulfate is shown in Scheme IV. 
The role of formate is interesting. It enhances the rate of 
inactivation of cAAT with 3-chloroalanine. Morino et al. (1974) proposed 
that formate ion was involved in a charge relay system in the active 
site. The authors concluded that the formate ion replaced the distal 
carboxyl group of the substrate and that this carboxyl interacted with an 
active site histidyl residue necessary for a charge relay system. 
However, recent X-ray crystaliographic studies show that no histidyl 
residue is present in the substrate-binding region (Metzler et al., 1981). 
Irreversible inactivation of aspartate aminotransferase with 
vinylglycine was reported by Rando (1974b), and Gehring et al. (1977b). 
Inactivation was time dependent, and the enzyme was protected by the 
presence of aspartate. Mercaptoethanol did not have any effect on 
inactivation. Inactivated enzyme absorbed light at 335 nm. This 
absorption band did not shift position either upon treatment with 
borohydride or upon change of pH (Rando did not state the pH range). 
Rando (1974b) suggested that the 335 nm band represented a pyridoxamine 
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derivative. Gehring et al. (1977b) showed that inactivation was 100 % 
complete when cc-ketoglutarate was present. The 335 nm form released its 
chromophore when treated with 10% trichloroacetic acid or 0.1 M sodium 
hydroxide. The chromophore released was identified as PLP by absorption 
spectroscopy and by high voltage paper electrophoresis. A chymotryptic 
peptide containing the radioactive label and chromophore was isolated and 
analyzed for amino acid content. The results showed equimolar amounts of 
Asp, Ser, Phe, and a peak that cemigrated with homoserine lactone. From 
the known sequence, the peptide sequence was matched with an active site 
tetrapeptide. Dansylation, digestion with aminopeptidase î-î, and digestion 
with carboxypeptidase C confirmed the sequence, Ser-Lys*-Asn-Phe. As with 
g-chloroalanine, Lys-258 was the actual base modified. Gehring et al. 
(1977b) did not treat the inactivated enzyme with borohydride before the 
cyanogen bromide digestion. The proposed mechanism of inactivation of AAT 
with vinylglycine is shown in Scheme V. The pathway is quite analogous to 
the one with serine sulfate and gr-chloroalanine (see Scheme IV). An 
a, g-unsaturated intermediate (V^) similar to the a-aminoacrylate Schiff 
base intermediate (IV^) was proposed. The ^-position of the substrate is 
then presumably attacked by the s-amino group of Lys-258 and covalently 
modified. 
Recently Cooper et al. (1982) showed that g-methyleneaspartate acts 
as mechanism-based inactivator upon aspartate aminotransferase. This 
compound has been used in the study of the carbon skeleton rearrangement 
during a reaction catalyzed by the vitamin Bi2-dependent enzyme, 
methylaspartate mut ase (Barker et al., 1958). Incubation of cytosolic 
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aspartate aminotransferase with g-methyleneaspartate results in a 
time-dependent loss of enzyme activity. It is accompanied by the loss of 
the absorption maximum at 430 nm of native enzyme and the appearance of a 
new peak at 335 nm. The latter peak is also seen for other mechanism-
based inhibitors described in this section. Incubation of the enzyme with 
3-methyleneaspartate in the presence of 60 mM 2-mercaptoethanol, 
dithiothreitol, or glutathione does not reverse the inactivation. Cooper 
et al. proposed a possible mechanism; 1) g-methyleneaspartate reacts with 
pyridoxal phosphate at the active site yielding an aldimine vrtiich is 
converted to a ketimine. 2) Nucleophilic attack on the methylene carbon 
of the conjugated ketimine by residue X of the enzyme leads to an inactive 
form. Inhibition constant (K^) of around 3 mM for g-methyleneaspartate 
suggests strong binding of this compound to the enzyme. Inactivated 
enzyme released pyridoxamine phosphate when treated with a high phosphate 
concentration under condition used to convert holo-enzyme to apo-enzyme 
(Bertland & Kaplan, 1968). The formation of pyridoxamine phosphate was 
also observed after the inactivation of the enzyme with 2-amino-4-
methoxy-3-butenoic acid (Rando et al., 1976). Unfortunately in both cases 
the evidence for the quantitative release of pyridoxamine phosphate from 
the inactivated enzyme is weak. Cooper et al. also observed that the 
inactivation was not 100% complete. 
The naturally occurring bacterial toxin, L-2-amino-4-methoxy-trans-3-
butenoic acid (111^; AMB) was shown to inactivate AAT in a manner similar 
to that of vinylglycine (Rando et al., 1976; Rando, 1974b). Inactivated 
enzyme absorbed light at 350 nm, a position which was independent of pH 
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over the pH range 4-9. The proposed mechanism of the inactivation is 
shown in Scheme VI. The introduction of a poor leaving group (-OCH3) 
increased the structural complexity of this inhibitor over that of 
vinylglycine. Isomerization of the double bond from 6, Y to a, 3 was 
quite unfavorable in this case. Thus, the nucleophilic attack was more 
favorable at the T-position than at the ^-position. Because the -OCH3 
group was a poor leaving group, step c might be necessary before the 
release of methanol could occur. AMB also inactivates sheep liver 
threonine dehydratase and tryptophan synthetase (Miles, 1975a, b). Miles 
discussed a similar mechanism for tryptophan synthetase (1978). 
Another type of mechanism-based inactivation of aspartate 
aminotransferase was observed with L-propargylglycine (III^; Tanase & 
Morino, 1976). A possible mechanism is shown in Scheme VII. The key step 
is the formation of a 3-carbanionic intermediate, VII^. This is 
presumably converted to the reactive aliéné intermediate, VII^, which is 
then attacked by Lys-258 to give inactivated form, Vllg. The importance 
of abstraction of the a-proton during inactivation with propargylglycine 
was suggested by Marcotte and Walsh (1975). Marcotte and Walsh found that 
those enzymes that released g-protons were inactivated by 
propargylglycine. Such enzymes are cystathionine y—synthetase, alanine 
aminotransferase, y-cystathionase (Abeles & Walsh, 1973; Washtien & 
Abeles, 1977). 
Tanase and Morino (1976) found that propargylglycine alone did not 
inactivate either cytosolic or mitochondrial aspartate aminotransferases. 
However, in the presence of ot-ketoacid, such as o-ketoglutarate, or 
pyruvate, gradual inactivation of AAT was observed with propargylglycine. 
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Inactivation was enhanced in the presence of 3 M formate. The formate 
effect was more drastic on the cytosolic than on the mitochondrial 
isoenzyme. This observation was analogous to that on the reaction with 
S-chloroalanine (Morino et al., 1974). Light absorption of the native 
enzyme at 362 nm shifted to 340 nm and 385 nm after the inactivation. A 
negative CD at 340 nm and a positive CD at 385 nm were also observed. 
Alanine aminotransferase was found to exhibit only one absorption band at 
325 nm when it was inactivated by propargylglycine (Marcotte & Walsh, 
1975). 
Evidence For the Existence of Reactive Intermediates During Mechanism-
Based Inactivation Reactions of Pyridoxal Phosphate Dependent Enzymes 
Cavallini et al. (1973) reported a protective effect of thiosulfate 
upon the inactivation of aspartate aminotransferase by serine-O-sulfate. 
Incubation of AAT with serine sulfate in the presence of thiosulfate did 
not lead to inactivation. Instead, cysteine-S-sulfonate was found as a 
product. The following scheme (VIII) was suggested by Cavallini et al. to 
explain this fact. The reactive intermediate (VIII^), an a-amino-
acrylate Schiff base, was trapped by the attack of the thiol group of 
thiosulfate before it could be modified by reaction with the active site 
residue, Lys-258. The trapped form (VIII-p) was spontaneously converted to 
the native form (VIII^) and the product, cysteine-S-sulfonate. 
Soper and Manning (1978, 1981) reported a mechanism-based 
inactivation of bacterial D-amino acid transaminase with g-haloalanines. 
Experiments to trap the key intermediate in the reaction were carried out 
(Soper & Manning, 1978). When the enzyme was incubated with g-chloro-D-
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alanine in the presence of 3-mercaptoethylamine, it was protected from 
inactivation. The substrate continued to be consumed, but no pyruvate was 
fcrniad. The authors isolated the products and identified a zajor product 
as S—(g-aminoethyl)cysteine and a minor one as A^-thiomorpholine-2-
carboxylic acid. An a-aminoacrylate Schiff base was proposed as the 
reactive intermediate. The proposed scheme for the inactivation reaction 
of D-amino acid transaminase is shown in Scheme IX. 
The formation of an a-aminoacrylate Schiff base has been proposed not 
only during mechanism-based inactivation, but also as a normal part of 
some pyridoxal-linked enzymatic reactions (Snell & DiMari, 1970; Davis & 
Metzler, 1972), Davis and Metzler reviewed the spectrophotometric 
evidences for the a-aminoacrylate Schiff base. The peak at 470 nm was 
assigned to a-aminoacrylate Schiff base by Soda (1967) and by Cook and 
Wedding (1976) in the reaction of 0-acetylserine sulfhydrylase with 
0-acetyl-L-serine. A 455 nm band was reported by Tokushige et al. (1968) 
and Robinowitz et al. (1973) for aminocrotonate in the reaction 
ofthreonine dehydrase with L-threonine. Tryptophan synthetase with 
L-serine gave a spectrum ^ ich clearly showed a strong shoulder at 468 nm, 
representing an a-aminoacrylate intermediate (Goldberg & Baldwin, 1967). 
A peak position around 450-470 nm is reasonably assigned to 
a-aminoacrylate intermediates; however, no direct observation of this 
intermediate has been reported during laechanism-based inactivation 
reactions. The problem may be that the lifetime of a-aminoacrylate Schiff 
base may not be long enough. Recently Schnackerz et al. (1979) did 
observe the formation of an a-aminoacrylate Schiff base with bacterial 
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D-serine dehydratase. Stopped-flow techniques were used to observe a 
transient 455 nm form. The half-life time of the absorbance at 455 nm was 
6.5 ms in the reaction of bacterial D-serine dehydratase with D-serine. 
Moreover, Schnackerz et al. (1979) synthesized a transient-state analog of 
the a-aminoacrylate-pyridoxal phosphate Schiff base (X) and observed the 
formation of a 460 nm peak when the analog was 
C O O H  
0© HO 
X 
Scheme X. 
incubated with the apo-D-serine dehydratase. The analog was bound so 
tightly that treatment of the complex by dialysis or gel filtration did 
not release the analog. Yang et al. (1975) made complexes with 
apo-aspartate aminotransferase and 4-vir.yl, and 4-ethynyl analogs of 
pyridoxal phosphate. None of the analogs showed absorption around 450-470 
nm. It was presumably because they lack a second conjugated double bond 
outside the ring and also perhaps because of the absence of a nitrogen 
atom in their bond system. 
One of the direct ways to learn the nature of the inactivated enzyme-
substrate complexes is to determine the structural arrangement of the 
complexes. X-ray crystallography, of course, is the most powerful tool 
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for this purpose. Experiments to obtain difference density maps are in 
progress in Arnone's laboratory using AAT crystals vrtiich are modified with 
serine sulfate (private communication with Dr. A. Arnone, University of 
Iowa). Chemical degradation of the inactive enzymes has been used as the 
the most successful approach to investigate the structure of the 
inactivated form. Washtien and Abeles (1977) reported the mechanism-based 
inactivation of y-cystathionase with propargylglycine. The acid 
hydrolysis of labelled Y-cystathionase gave a product identified as 
2-amino-4-ketopentanoic acid (XI^). Its formation is shown in Scheme XI. 
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Wang et al. (1981) carried out similar experiments on the product of 
serine transhydroxymethylase with D-fluoroalanine. Two radioactive 
compounds were isolated after the treatment of the complex with 6M urea, 
KBH4, then acid hydrolysis. The products were identified as lanthionine 
and S-carboxyhydroxyethylcysteine by comparing the migration on TLC with 
that of synthetic reference compounds. The residue involved in 
inactivation was postulated to be cysteine. Base treatment of the 
inactivated complex of glutamate decarboxylase with serine sulfate is 
another example (Likos & Metzler, 1976). The yellow colored chromophore 
released is characterized and is described in this thesis. 
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METHODS 
Materials 
All chemicals used were of reagent grade. L-serine-O-sulfate was 
synthesized according to the procedure of Tudball (1962). The purity and 
authenticity were checked using high voltage electrophoresis and NMR. 
Synthetic 4-[2-methyl-3-hydroxy-5-(phosphooxymethyl)-4-pyridinyl]-
2-oxo-3-butenoic acid 2, and synthetic 4-[2-methyl-3-hydroxy-5-
(hydroxymethy1)-4-pyridiny1]-2-oxo-3-butenoic acid 3, were prepared by 
John Likos (Monsanto Co., St. Louis, Mo.) according to the procedures 
described by Schnackerz et al. (1979). Synthetic 5, the NaBH^ reduction 
product of 3, was also prepared by J. Likos in a crystalline form. 
Absorption Spectra 
Absorption spectra were measured with a Gary 1501 recording 
spectrophotometer interfaced through a Cary-Datex digital output to an 
IBM card punch. Spectra were corrected for baseline errors and small 
amounts of turbidity. The data were replot ted automatically as apparent 
molar absorptivity or absorbance vs. wave number (Johnson & Metzler, 
1970; Metzler et al., 1973). The method of Nagano and Metzler (1967) was 
used to evaluate pK values, to plot spectrophotometric titration curves 
and to calculate the spectra of the individual ionic forms of the 
compounds studied. A Gary 219 spectrophotometer was also used. 
Nuclear Magnetic Resonance Spectra 
Spectra were recorded using a Bruker WM300WB spectrometer equipped 
with a wide bore 300 MHz superconductive magnet, variable temperature 
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control unit, Diablo 44d disk, Aspect 2000 computer with 48K (24-bit 
words) memory, and an advanced software, DISNMR. Samples for nuclear 
magnetic resonance (NMR) spectra were typically 0.2-40 mM in chromophore 
concentration (total amount 0.1-20 mmol). High quality NMR tubes (5 mm 
inner diameter, #527-PP, Wilmad Glass Co.) were used. The volume of the 
samples was limited to 0.5 mL. Deuterium oxide was used as an internal 
lock signal and solvent; to avoid an undesirably high HDD peak, "100 % 
D2O" was used. Special care was taken in handling the 100 % D2O. The 
necessary volume of D2O was taken up into a well-dried syringe which had 
been filled with dry N2 gas. Chemical shifts were recorded in parts per 
million (ppm) relative to an external standard present in a capillary 
tube. A disposable micropipette of 5-10 vL volume was used as a 
capillary. It was filled with deuterated chloroform containing 1 % of 
tetramethylsilane (TMS) and was then sealed by torch. The external 
standard exhibited one major peak for TMS at 0.0 ppm and two small peaks 
for CHCI3 at 1.5 and 7.2 ppm. Typically 16 K words of computer memory 
were used for measurements giving a digital resolution of 0.49 Hz. A 
30° flip angle (2.1 ys pulse) was employed with a delay time of 1.0 s 
while the water peak was decoupled. When decoupling was not carried out, 
the delay time was shortened to 0.1 s. 
Carbon 13 NMR spectra were recorded at 75.5 MHz using 10 mm tubes. 
Broad band decoupling (1-2 Watts) was employed during the measurements 
unless otherwise indicated. An external capillary containing dioxane was 
used as a standard. Observed chemical shifts were made relative to TMS 
by adding 66.5 ppm. Typically 32 K words of computer memory giving a 
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digital resolution of 1.22 Hz, a 60° flip angle (15 ps pulse) and an 0.2 s 
delay time were employed. To assign the resonances, broad band 
decoupled, gated decoupled, or specific proton decoupled spectra were 
taken and compared. 
The value of pD was estimated by adding 0.41 to the reading on a 
Radiometer model PHM 64 pH meter. The pD of the sample was adjusted by 
adding DCl (20% in D2O) or NaOD (40% in D2O). 
Other NMR instruments such as JOEL FX90Q, Bruker WH90, Varian HA-100, 
Hitachi-Perkin Elmer R20B, or Varian A-60 were also used. 
Amino Acid Analysis 
Amino acid analysis was performed on a Durrum D 400 analyzer by W. 
Harris after hydrolysis of the samples in 6N HCl at 110°C for 22 h. 
Gas Chromatography 
Gas chromatography was carried out with a Packard-Becker nsDdel 419 
chromatograph. The instrument had a flame ionization detector. The 2.4 m 
X 2 mm glass column was packed with 3% Dexil 300 on Chromosorb W AW DMCS 
100/120 mesh. The column temperature was programmed from 120 to 300 "C at 
15 °C/min. The injection port temperature was 260 °C, and the detector 
temperature was 310 'C. The flow rates of H2, air, and the carrier gas 
(Ar) were 25, 250, and 20 mL/min, respectively. Experiments were also 
done in Professor J. Fritz's laboratory using a Tracor 550 gas chromato­
graph with a Tracor 702 N-P detector. An OVl column (1/4" x 6') was used. 
Mass Spectra 
Mass spectra were measured by S. Vesey and J. Bean at the ISU 
Chemistry Instrument Services using a Finnigan 4000 GC-MS data system or 
an AEI MS-902 mass spectrometer. 
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Enzymes 
L-Glutamate decarboxylase was isolated from Escherichia coli (ÂTCC 
11246) as described by Fonda and DeGrella (1974). The following 
improvements were done. The final two steps make use of columns of 
DEAE-Sephadex A50 and Sephacryl S200, respectively (Figures 1 & 2). It 
was found that during the first of these steps, a protein "factor" 
running behind the glutamate decarboxylase was sometimes separated from 
the enzyme (Figure 1). It was necessary to add this factor back to the 
enzyme before a rapid reaction with serine sulfate could be observed. 
Molar concentrations of the enzyme active sites were calculated from the 
heights of the absorption bands at 420 nm at pH 4.6 assuming a molar 
absorptivity of 10,000 (Fonda, 1971). Enzyme activity was determined 
using a Gilson differential respirometer (Fonda, 1971). 
The a sub form of cytosolic aspartate aminotransferase was isolated 
from pig hearts as described by Martinez-Carrion et al. (1967; see also 
Yang & Metz 1er, 1979). 
Partial Purification of Protein Factor 
Fractions numbers 90-160 following the glutamate decarboxylase on 
the DEAE-Sephadex A50 column (Figure 1) were pooled and concentrated. 
The concentrate was passed through a column of Sephacryl S200 using the 
same conditions as were used for the final step in the purification of 
the glutamate decarboxylase (Yang & Metz1er, 1979). Using the assay 
described in the following section, three major protein bands were 
separated; protein factor was located in the third band (Figure 3). 
Figure 1. Chromatography of Glutamate Decarboxylase and Protein Factor on DEAE-Sephadex A50 
Solid line shows the elution profile followed at 280 nm, and the solid line with open 
circles indicates the protein factor activity (tubes no. 90-160). Glutamate 
decarboxylase activity was found in tubes no. 78-85. 
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Figure 2, Chromatography of Glutamate Decarboxylase on Sephacryl S200 
Glutamate decarboxylase was prepared by column chromatography on DEAE-Sephadex A-50. 
Absorbance at 280 nm is plotted versus tube number. Glutamate decarboxylase activity 
was found in tubes 53-60. 
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Molecular Weight Estimate for the Protein Factor 
The molecular weight of the partially purified protein factor was 
estimated by electrophoresis in 10 % acrylamide gel in the presence of 
sodium dodecyl sulfate. The gel was calibrated with four proteins; 
ribonuclease A (M^ = 13,700), chymotrypsinogen (Mj- = 25,000), ovalbumin 
(Mj. = 43,000), and bovine serum albumin (M^. = 67,000). The migration of 
proteins (as Rf) was plotted versus log (Figure 4). Here Rf is 
defined as the mobility of a protein divided by the mobility of the 
marker dye, bromophenol blue. The position of this dye was marked on the 
gel prior to staining with Coomassie blue. 
Assay for the Protein Factor 
Protein factor that had been partially purified by chromatography as 
described above was tested with highly purified glutamate decarboxylase. 
Glutamate decarboxylase (37.2 nmol) in acetate buffer (0.1 M, K"*" 
salt, pH 4.6) and L-serine-O-sulfate (17.8 vmol) were mixed in a cuvette 
in a volume of 0.62 mL at 25 °C. The absorbance (Ag = 0.60) at 417 nm 
did not change significantly with time. A portion of protein factor 
(5-30 pL volume) was added and the absorbance change at 417 nm was 
recorded versus time (Figure 5). The final (infinite time) absorbance A^ 
for the biphasic reaction was estimated (A^ = 0.016) and a graph of 
logio (Aj. - A^) against time (Figure 6) was prepared where A^ was the 
absorbance at time t after addition of the protein factor. The apparent 
first order rate constants (k) for the second phase of the reaction were 
Figure 3. Chromatography of the protein factor on Sephacryl S200 
The eluent was monitored at 280 nm (solid line). The line with the open circles 
indicates the protein factor activity. 
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Figure 4. Molecular weight of protein factor by gel electrophoresis in the presence of sodium 
dodecyl sulfate 
Open circles represent kno*m marker proteins. 1 represents glutamate decarboxylase. 2 
represents protein factor. 
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Figure 5. Effect of protein factor on reaction of glutamate 
decarboxylase with serine sulfate 
Glutamate decarboxylase (37.2 nmol) and L-serine-O-sulfate 
(17.8 yinol) were mixed with various amounts of the protein 
factor in the cuvettes to adjust the final volume to 0.62 mL. 
The amounts of the protein factor added are indicated in units 
of microliters. Initial (Ag) and final (.A^) absorbances were 
and 0.016, respectively. The absorbance at 417 nm is plotted 
versus time. 
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Figure 6. Semilogarithmic plot of the changes in absorbance at 417 nm 
with time 
Numbers indicate the amount of protein factor added in 
microliters. 
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estimated from the slopes (slope = -k/2.303) in the above graph (Figure 
6). These rate constants are plotted against the amount of protein 
factor in Figure 7. A unit of protein factor activity was defined as 
follows (3): 
1 unit = 10 / ti/2 
= 10k / ln2 
= 14.4 k, (3) 
where k was the apparent first order rate constant for the second phase 
of the decay with the specific amount of glutamate decarboxylase (37.2 
nmol). 
Preparation of the Initial Product ( 1 ) of Reaction of Serine Sulfate 
with Glutamate Decarboxylase 
In a typical preparation, 52.5 mL of 6.1 x 10"^ M glutamate 
decarboxylase (160 mg of protein; 3.2 ymol) in 0.1 M potassium acetate 
buffer, pH 4.6, containing 10"^ M dithiothreitol was used. To this 
solution was added 62 mg of solid L-serine-O-sulfate (to give a final 
/-«o r» f ^ thM ^ rtor» ÔC C a 0 AO t«T . of p crv 1 n f* "î 
the protein factor that had been separated from the enzyme. This 
contained 13 units of activity as defined in the preceding section. The 
reaction mixture was left at room temperature for about 6 h during which 
the absorbance at 420 nm dropped from 0.607 to 0.093. The modified 
enzyme (.1) formed in this case was dialyzed overnight against three 
2-liter portion of redistilled water. 
Figure 7. The apparent rate constant versus the amount of protein factor 
The apparent first order rate constants for the second phase of the reaction were 
obtained from the slopes in Figure 6. 
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Preparation of the Products la, lb, and Ic of Reaction of Serine Sulfate 
With Cytosolic Aspartate Aminotransferase 
In a typical reaction, a 25 inL volume of 2.8 x 10"^ M aspartate 
aminotransferase (316 mg of protein, 6.8 ymol of pyridoxal phosphate) in 
0.04 M sodium acetate buffer, pH 5.4, was used. To this was added 70 mg 
of solid L-serine-O-sulfate to give a concentration of 12.6 mM. After 10 
min at room temperature, the enzyme was converted almost quantitatively 
to the inactive form la. Over a period of 20 h at room temperature, the 
absorption maximum shifted from 336 nm to 455 nm (form lb). This form 
was stable as long as the solution was not dialyzed. However, dialysis 
against water for 8 h caused the disappearance of the 455 nm band and the 
formation of Ic, a form characterized by a 430 nm absorption band at pH 
5.4 and a 360 nm band at pH 8 (Morino et al., 1974). 
Preparation of the Low Molecular Weight Yellow Product 2 
The pH of a solution of compounds 1, la, lb, or Ic was raised to 
11.0 by addition of 0.1 N KOH. The resulting bright yellow compound 
(2) vas separated fron the protein by ultrafiltration through an Amicon 
PMlO membrane. When the volume of the protein solution had been reduced 
to 1-2 mL, it was diluted with 3-5 mL of 0.05 N KOH or water and again 
ultrafiltered. This "washing" was then repeated two more times and all 
the washings were combined with the initial ultrafiltrate. The resulting 
solution, which contained from 60 to 90% of the initially formed 
absorbance at 420 nm (see Table I), was passed through a thoroughly 
washed 0.7 x 6 cm column of Dowex 50 (x8, 100-200 mesh) ion exchange 
resin in the H"*" form. The resin was repeatedly treated alternatively 
Table la 
Yields of Products From the Reaction 
of Glutamate Decarboxylase and L-Serine-O-sulfate 
Volume 
(mL) 
Absorbance 
A (nm) 
mol* % 
GAD^ 30 0.35 (420) 1.05 100 
1 30 0.25 (420) 0.74 70 
2 30 0.20 (420) 0.61 58 
5 c 5 1.13 (311) 0.56 54 
®The molar absorptivity, e - 10,000 for native GAD was used for the calculation. 
^GAD = glutamate decarboxylase. 
^Compound 5 purified by gel filtration on BioGel P2. 
Table lb 
Yields and Apparent Molar Absorptivities of Compounds Derived From 
Serine Sulfate-treated Enzyme 
Compound Treatment Volume 
(mL) 
Absorbance 
A (^,nm) (M~ ^cm~^xlO~^) 
P mol % 
«-aspartate 
aminotransferase 24.5 18.24 (280) 65.50* 6.82 100 
2 20 h dialysis of la 
vs H2O, then to pH 11.5 32 15.1 (280) 
1.46 (415) 
71 
7.8lb 5.98 88 
2 After ultra-filtration 83 0.53 (415) 7.81 5.63 83 
3 After alkaline 
phosphataae 83 0.525 (310) 7.20c 6.1 89 
5 Treated with NaBH/j, 
then acidified 88 0.590 (282) 8.42d 6.17 90 
5 Chromatographed on 
DEAE-Sephadex 24 1.313 (308) 9.10 3.46 51 
5 Passed through Biogel 
P2 column 12.4 2.48 (312) 9.10 3.38 50 
GProm Furbish et al. (1969). See also Yang and Metzler (1979). 
^Based on pure synthetic 2. 
CBased on pure synthetic 3. 
^Based on pure synthetic 5. 
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avoid contamination of NMR samples in the aromatic region. The column 
was eluted with 10 mL of water. The measured pH of the eluate was 
5.0-5.5. The solution was concentrated under vacuum to the desired 
volume or was lyophilized. 
Another procedure developed by R. Feldhaus in this laboratory made 
use of SP-Sephadex (SP-G25, 40-120 mesh beads) in the H"*" form. This was 
prepared by treating the beads with 0.2 M HCl for 10 min and washing 
quickly with water. The treatment was repeated a second time. An 0.8 x 
15 cm column was prepared and washed with about 6 L of water. Compound 
2 from 100 mg of enzyme prepared with a minimum of KOH was passed 
through the column which was then washed with 20 mL of water. The 
combined effluent was lyophilized and taken up in D2O for NMR 
spectroscopy. Compound 2 prepared in this way was free of aromatic 
impurities; however, a number of impurities with upfield resonances, 
presumably sugar residues from the Sephadex gel, were detected by NMR. 
Two alternative methods were also developed for preparation of 2. 
(1) The pH of an inactivated enzyme solution was raised to 11.0 by the 
addition of 0.1 N KOH. Then a solid trichloroacetic acid was added to 
precipitate the protein. Over 90 % of the chromophore remained in the 
supernatant. It was necessary to use homogeneous enzyme for this 
experiment. Otherwise some proteins remained in the supernatant after 
the trichloroacetic acid precipitation. (2) Compound 2 was also 
isolated by chromatography on Sephadex G25 (1.5 x 46 cm). Compound i 
at pH 11 (0.2 Umol) was applied to the column of Sephadex G25, and was 
eluted with 0.05 N KOH. Only about 30-40 % of the chromophore was 
6 1  
(0.2 imol) was applied to the column of Sephadex G25, and was eluted with 
0.05 N KOH. Only about 30-40% of the chromophore was recovered without 
overlap with the protein absorption band. Thus, the separation was not 
sat isfactory. 
The purity of 2 was checked by either high voltage electrophoresis 
(HVE) or by thin layer chromatography (TLC). Sheets (23 x 57 cm) of 
Whatman 3mm paper were used for HVE with 0.1 M pyridine-acetate buffer, 
pH 6.5 as the electrolyte. HVE was conducted for 20 min at 2000 V. 
Under these conditions 2 had the greatest electrophoretic mobility and 
moved 6.5 cm toward the anode. The sample could be located by spraying a 
test strip of the electropherogram with Gibbs reagent (2,6-dichloro-
quinone-4-chloroimide) or by its distinct orange fluorescence when 
illuminated with ultraviolet light (Mineralight UVS 11). Silica gel 
plates from EM Merck were used for ascending thin layer chromatography 
with a 1-butanol-acetic acid-water (4:1:1) solvent. A weak yellow band 
which gave a positive result for Gibbs reagent and a characteristic 
fluorescence was observed at 0.25 cm (Rf = 0.015). 
Preparation of 3 by Dephosphorylation of 2 
Solutions of 2 at pH 11 as obtained by ultrafiltration of the 
inactivated and base-treated enzymes were adjusted to pH 8.1 with 0.05 N 
HCl. Approximately 0.03 mg of alkaline phosphatase from E. coli was then 
added. The dephosphorylation reaction was followed by the decrease in 
absorbance at 406 nm. After approximately 13 h at room temperature, the 
spectrum did not change further. The solution was lyophilized. The 
residue was dissolved in 0.6 mL of water and was passed through a 1.5 x 
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68 cm column of BioGel P2 with water as the eluant. Compound 3 emerged 
shortly after the void volume in a sharp band. Electrophoresis was 
carried out for 20 min at 2000 V. Under these conditions, the major 
product (as determined qualitatively by the intensity of the Gibbs test) 
migrated 2.5 cm toward the anode. 
Preparation of 4 By the Reduction of 2 
Compound 2 was reduced with sodium borohydride at pH 8. The 
reduction reaction was monitored by the decrease in the absorbance at 420 
nm. The solution was then acidified with 50 jiL of 6 N HCl to destroy the 
excess borohydride. 
Preparation of 5 by the Reduction of Isolated 3 
The pH of a solution of 3 was lowered to 7.0 with 0.1 N HCl. Solid 
sodium cyanoborohydride or borohydride was then added. The reduction 
reaction was followed by the decrease in the absorbance at 406 nm. The 
reaction solution was left overnight at room temperature and was then 
acidified by the addition of 50 viL of 6 N HCl. The product was partially 
^ ^ ^ ^  ^ ^ ^  1 ^ 1 ^  mm M ^ ^ ^ «to V ^ 1 /J to ^ ^ ^ Ç ^ A ^ ^ 1 ^ 1 \ 
^ ^ ^ -A. Jk .l.Ji.A.w*.C4W ^ jr ^ C. ^ V* C* O CaU/ L. _/ _//0 \0<C<C X CX L./ X C X / • 
Preparation of 6 by Dephosphorylation of 4 
The pH of a solution of 4 was adjusted to 8-9, then coli alkaline 
phosphatase (about 0.03mg) was added. The dephosphorylation reaction was 
run overnight at room temperature; then the solution was lyophilized. 
Alkaline Hydrolysis of 2 
To 200 Hi of a solution containing 18 nmol of GAD 2 in a 1.1 x 10 cm 
pyrex test tube, was added 20 liL of 1 M KOH. The pH was 12.5-13.0. The 
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test tube was sealed with a torch and was heated at 100 °C for 4 h. 
Portions of the solution as well as a sample of unheated 2 were assayed 
for pyridoxal phosphate as follows: the apo form of the cytoplasmic 
isoenzyme of aspartate aminotransferase of pig hearts was prepared by V. 
Chen according to Yang and Metzler (1979). The concentration was made as 
6.4 mg/mL (1.4 x 10"^ M) in 0.02 M triethanolamine hydrochloride-NaOH 
buffer, pH 8.3. To a series of 50 IL portions, each containing 7 nmol of 
the enzyme were added amounts of pyridoxal phosphate ranging from 0.05 to 
3 equivalents per equivalent of apoenzyme. After 10 min at room 
temperature, 10 mL of water was added to each tube. The diluted samples 
were then assayed for aspartate aminotransferase activity as described by 
Furbish et al. (1969; see also Yang & Metzler, 1979). 
Preparation of Model Compounds 
Commercially available compounds such as pyridoxal, pyridoxamine, 
pyridoxine, and dipeptides were used without further purification. 
Reduced Schiff bases of pyridoxal with alanine, isopropylamine, and 
ethanolamine were synthesized and crystallized as follows. Pyridoxal.HCl 
(3.7 mmol) was mixed with 5.7 mmol of amine in 20 mL methanol at pH 10. 
Solid sodium borohydride was added until yellow color diminished, then pH 
was lowered to 5 with 6N HCl. After dryness, the product was 
redissolved in 10 mL of water and loaded on CG 50 column (1.5 x 45 cm) 
eluted with water. About 1.5 L of water was required to elute pure 
product off the column. The product was monitored by its absorption at 
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326 nm at neutral pH. The pooled fraction was concentrated to about 20 
mL and the product was crystallized from ethanol/water. Purity was 
checked by TLC, high voltage electrophoresis, or NMR spectrum. Reduced 
ethanolamine-pyridoxal Schiff base gave Rf = 0.24 (TLC), mobility of 14 
cm toward anode (electrophoresis). 
Permethylation of Model Compounds 
The compounds were subjected to permethylation, first described by 
Hakomori (1964) and reviewed by Morris (1980). 
To avoid forming quaternary ammonium salts of the free amino group 
during methylation (described later), the compound was acetylated first. 
Four volumes of dry methanol were mixed with one volume of acetic 
anhydride. To 100-500 nmol of model compound, 0.5 mL of the above 
mixture was added. The mixture was allowed to stand at room temperature 
for 3-4 h. Then the reagents were removed in vacuo. 
N-, 0-, or S-permethylation is done with methyl iodide, using the 
methylsulfinylmethide carbanion as a catalyst. The carbanion is produced 
as follows: An amount of NaH/oil dispersion containing 120 mg (5 mnsol) 
NaR is rinsed 3 times with hexane. Five TUL of dry dimsthylsulfoxids is 
added and the suspension is heated under nitrogen until evolution of 
hydrogen has ceased. The resulting clear solution has 1 mmol/mL of DMSG" 
and is kept for several weeks stored under nitrogen at 0 °C. 
The acetylated compound (about 10 Pmol) is dissolved in 50 jiL of 
DMSO. Under nitrogen, 50 PL of the carbanion solution is added (about a 
5-fold molar excess). After 10 min, 8 yL of methyl iodide is added under 
nitrogen (10 fold molar excess). The reaction proceeds at room 
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temperature for 5 min. I have varied this reaction time from 1 min to 12 
h and found that 5-10 min was optimal. The reaction is terminated by the 
addition of 1 mL of water. The permethylated compound is extracted by 
shaking with 1 mL of chloroform and removing the water layer. The 
chloroform layer is then washed 3 times with 1 mL of water, and 
introduced into the GC-MS spectrometer. Overreaction causes methylation 
of the ring nitrogen which becomes a quaternary ammonium ion and 
therefore not extractable with chloroform. 
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RESULTS 
Reaction of Glutamate Decarboxylase With Serine Sulfate 
The reaction of glctazate decarboxylase with serine sulfate was 
extensively investigated by Likos (1977). Likos described the reaction 
of serine-O-sulfate (12.5 mM) and glutamate decarboxylase (4.1 x 10"^ M) 
which had been purified through the step of chromatography on DEAE-
Sephadex A50 were incubated in 0.05 M sodium acetate buffer, pH 4.6, at 
23 °C. Six microliter aliquots were taken at timed intervals and were 
assayed for decarboxylase activity (the dilution into the 3 mL assay 
mixture containing glutamate quenched the inactivation reaction immedi­
ately). Activity decayed very rapidly at first but more slowly later. 
Half of the activity was lost in the first five minutes. Less than 10 % 
remained after 90 min and the enzyme was totally inactivated in 4 h. 
Preliminary kinetic studies have been also reported by Likos (1977). 
Protein factor 
Several batches of enzyme which I prepared reacted just as described 
in the preceding paragraph. However, later I obtained a presumably more 
highly purified enzyme that failed to react with serine sulfate. At this 
point, I began to add back other fractions from the DEAE-Sephadex A50 
column and discovered that a fraction running behind the glutamate 
decarboxylase (Figure 1) enhanced dramatically the rate of reaction with 
serine sulfate, while the kinetics of the inactivation reaction were 
biphasic (Figures 5 & 6), the rate was determined largely by the 
concentration of the factor present in this fraction. An assay for the 
factor was devised and a partial purification was achieved as described 
in METHODS. The partially purified factor has an absorption maximum at 
280 nm. It is destroyed by boiling. It can be concentrated using an 
Amicon PMIO ultrafiltration membrane and is not lost upon prolonged 
dialysis against acetate buffer, pH 4.6. The factor activity was not 
removed when a solution of the factor was mixed vigorously with 1/5 
volume of activated charcoal for 10 min. The presence of up to 0.2 M 
"ëtfi^enedî^inetetraacetic acid~^T)TS)"^3id not inhibinAe factor 
activity significantly. Treatment of the factor with trypsin appeared to 
lead to loss of the factor activity. A carbohydrate color test was 
carried out (Table II). A significant increase in absorbance at 490 nm 
was observed using the factor isolated from chromatography on 
DEAE-Sephadex A50. The results indicate that the factor is neither a 
nucleotide nor a metal related compound. It is likely that the factor is 
a protein with molecular weight greater than 10,000. However, it is not 
clear whether or not the factor contains some kind of carbohydrate. 
Additional evidence was given by the dialysis experiment (Table 
III). The reaction of glutariate decarboxylase and serine sulfate was 
carried out in a dialysis tube in the presence of the factor either 
inside or outside of the dialysis membrane. After 4 h dialysis, the 
spectra of the enzyme solution were measured, and the decreases of 420 nm 
absorption bands were recorded. The results were as follows, (a) 
Glutamate decarboxylase dialyzed against buffer which contained serine 
sulfate alone or serine sulfate plus the factor decreased in absorption 
at 420 nm only 10-15 % compared to the original height, (b) Glutamate 
decarboxylase together with the factor dialyzed against serine sulfate-
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Table II 
Carbohydrate Color Test& 
Absorbance at 490 nm 
H2O + phenol^ 0 .11  
2C + H2O 0.13 
2^ + phenol 0.76 
GAD^ + pheno1 0 .21  
PF® + phenol 0.50 
^0.5 inL of sample was mixed with 0.5 mL of 5% phenol (5 
g/100 mL of H2O). To the mixture was added 2.5 mL of concentrated 
A2SO4 and the solution was mixed vigorously. Then, the absorbance 
at 490 nm was measured. 
^5% phenol. 
^60 nmol of 2. 
^Glutamate decarboxylase, 
GProtein factor; isolated by chromatography on DEAE-Sephadex 
A50. 
69 
Table III 
Dialysis Experiment^ 
Inside dialysis tube Outside dialysis tube % Completion 
of reaction^ 
GAD^ (0.15 pmol) Serine sulfate (20 mg) 15 
GAD + PF*^ (0.2 mL) Serine sulfate 94 
GAD Serine sulfate 
9 
+ PF (1 mL) 
^3 mL of 0.1 M potassium acetate buffer, pK 4.6, was used as 
dialysis buffer, 
completion of reaction was calculated based upon the change of 
absorbance at 420 nm. Dialysis was conducted for 4 h at 4 "C. 
^Glutamate decarboxylase. 
dprotein factor. 
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containing buffer decreased its spectrum by 94%. The results suggest 
that the factor has a high molecular weight and interacts directly with 
glutamate decarboxylase. When the protein factor and serine sulfate were 
added together to the enzyme, the results were as shown in Figures 5 & 
6. However, if the protein factor was preincubated with the GAD for 10 
min prior to addition of serine sulfate only the slow phase of the 
biphasic reaction was observed. 
The protein factor was subjected to electrophoresis in polyacryl-
amide gels with and without sodium dodecyl sulfate (SDS) (Figures 8 & 
9). The gels were stained with Coomassie brilliant blue R-250. One 
major band was shown using either type of electrophoresis. The apparent 
molecular weight of the SDS denatured factor was estimated as 32,800 
(Figure 4). The molecular weight of GAD estimated using the same method 
was 44,000 (Figure 4). This value is close to 45,000-48,000, reported by 
Strausbauch and Fischer (1970a) using a similar method. The partially 
purified factor had no effect on the electrophoretic mobility of 
glutamate decarboxylase if both were mixed prior to the electrophoresis 
(Figure 9) and had only a small effect on the enzymatic activity of 
glutamate decarboxylase acting on its normal substrate. 
Properties of GAD I 
Likos investigated the properties of the enzyme inactivated with 
serine sulfate and his description is as follows. The inactive product, 
designated 1, has a well-defined absorption maximum at 336 nm whose 
position, shape, and intensity are characteristic of a substituted 
3-hydroxypyridine compound in a dipolar ionic form. 
Figure 8. Sodium dodecyl sulfate polyacrylamide slab gel patterns of the glutamate decarboxylase 
and the protein factor 
10 % gel was prepared (see text). 
a. Glutamate decarboxylase purified on DEAE-Sephadex A50 (20-30 Ug). 
b. Glutamate decarboxylase purified on Sephacryl S200 (5-10 Mg). 
c. Protein factor purified on Sephacryl S200 (30-50 lig). 
d. Protein factor purified on Sephacryl S200 (30-50 Ug). Prepared separately from c. 
Both c and d were overloaded intentionally in order to see the contaminations. The 
molecular weight indicated for glutamate decarboxylase and protein factor were 
obtained from separa t e  exper imen t s .  

Figure 9. Polyacrylamide slab gel patterns of glutamate decarboxylase 
and the protein factor 
7.5 % gel was prepared (see text). 
a. Glutamate decarboxylase purified on Sephacryl S200 (5 yg) 
(1, hexamer; 2, probably dimer; 3, probably monomer). 
b. Protein factor purified on Sephacryl S200 (5 yg). 
c. Glutamate decarboxylase (5 yg) and protein factor (5 Pg) 
were mixed together prior to gel electrophoresis. 
a 
CVlfO 
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Dialysis of the inactivated enzyme (compound 1) against 0.05 M 
acetate buffer, pH 4.6, for 24 h did not alter the spectrum. Assuming 
that the molar absorptivity at 282 nm is the same as that of the holo-
enzyme (88,000 M~^ cm~^, based on monomer, Fonda, 1971), the molar 
absorptivity of the chromophore was estimated as 8.2 x 10^ cm~^ at 
336 nm. Analysis of the supernatant fluid after the inactivated enzyme 
had been precipitated with trichloroacetic acid indicated that the 
chromophore was precipitated with the protein. By contrast, reaction of 
the enzyme with a-methylglutamate gave a product (pyridoxamine phosphate) 
that absorbs at 325 nm and which is easily separated from the protein. 
Dialysis of 1 overnight against 8 M urea in 0.05 M acetate buffer, 
pH 4.5, led to a hypsochromic shift of about 8 nm and 50% decrease in 
absorbance at the 336 nm peak (relative to the 280 nm peak height). This 
change did not appear to involve any loss of coenzyme. %en 1 was 
denatured with 10 M urea and the protein was precipitated with 
trichloroacetic acid, no 3-hydroxypyridine compound was released. By 
comparison, precipitation of the native enzyme with trichloroacetic acid 
releases about 35% of the bound pyridoxal phosphate. 
Reaction of Cytosolic Aspartate Aminotransferase With Serine Sulfate 
I found that the reaction product of aspartate aminotransferase with 
serine sulfate gave an identical product 2 with base. The use of 
aspartate aminotransferase for completion of the structure determination 
for compound 2 was attractive since it can be isolated in gram quantity. 
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In agreement with the report of John and Fasella (1969), treatment 
of aspartate aminotransferase (AAT) with L-sarina-O-sulfata causas a 
rapid loss of the 430 nm absorption band present at low pH, appearance of 
a new band at 336 nm (Figure 10) and inactivation of the enzyme. With 10 
mM serine sulfate, over 95% of the catalytic activity is lost within 5 
min at 25 °C. I designate the product of this initial reaction la. 
Over a 20 h period at room temperature, ia is converted to a second 
inactive species lb, which has an absorption maximum at 455 nm (Figure 
10). This conversion occurs at either pH 5.4 or pH 8 and under either O2 
or N2 at similar rates. However, at 5 "C la is quite stable and is 
transformed only very slowly into lb. It should be noted that 
conversion of la to lb never seems to be quite complete. A shoulder of 
variable height always remains at about 336 nm. Form lb is presumably 
identical to the 455 nm form of aspartate aminotransferase formed from 
3-chloroalanine (Morino et al., 1974). 
As reported by Morino et al. (1974). the spectrum of lb is altered 
by dialysis against water, the absorption maximum shifting from 455 to 
360 nm (Ic, Figure 12). The process is reversible, dialysis against 3 M 
formate converting the 360 nm band (Ic) back to 455 nm (lb). The 455 nm 
band is formed by reaction of the enzyme with serine sulfate at either pH 
8.3 or pH 5.4. No change in spectrum with pH is seen. However, after 
dialysis against water the 360 nm band of Ic shifts reversibly to 430 nm 
when the pH is lowered to 5.4. Compound Ic has an absorption spectrum 
similar to that of the native enzyme, but it has no catalytic activity. 
When lb is boiled, no chromophore is released. 
Figure 10. Reaction of aspartate aminotransferase with serine sulfate 
Formation of compound la. 
A = An electronic spectrum of native enzyme. 
B = An electronic spectrum of la, 10 min product. 
C = An electronic spectrum of reduced la. 
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Figure 11. Reaction of aspartate aminotransferase with serine sulfate 
Formation of compound lb and 4. 
A = An electronic spectrum of lb, 20 h product. 
B = An electronic spectrum of reduced lb. 
C = An electronic spectrum of 4, obtained heat treatment of 
reduced lb. 
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Figure 12. Reaction of aspartate aminotransferase with serine sulfate 
Formation of compound Ic. 
A = An electronic spectrum of lb. 
B = An electronic spectrum of Ic at pH 5.4, obtained after 
dialysis of ib against buffer. 
C = An electronic spectrum of Ic at pH 8.45, obtained after 
dialysis of lb against buffer. 
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However, after borohydride reduction a diffusible compound with an 
absorption maximum at 325 nm is freed from the protein by boiling (Figure 
1 1 ) .  
Reaction of g Subform of Aspartate Aminotransferase With Serine Sulfate 
The g subform of aspartate aminotransferase (1.4 x 10"^ M) was 
inactivated with serine sulfate (final concentration 12 mM) (Figure 13). 
The reaction was analogous to that of the g subform. Initially, a 336 nm 
band (la) appeared on the top of 340 nm band, then the formation of 455 
nm form (lb) was observed over a 20 h period. The reduction of the 455 
nm form by sodium borohydride at pH 5.3 gave two overlapping absorption 
bands at around 345 and 370 nm. 
Properties of la 
The absorption band of la at 336 nm is in the same position as that 
of the corresponding inactivated form of bacterial glutamate 
decarboxylase (1). Compound la is stable at low temperature and against 
prolonged (1 week) dialysis versus water at 4 "C. Treatment of la with 
solid sodium borohydride causes no change in the spectrum (Figure 10). 
incubation of either la or reduced la with 0.3 mM pyridoxal phosphate did 
not cause any reactivation of the enzyme. 
Heating la in a boiling water bath for 2 min caused denaturation of 
the protein and release of about 50% of the chrcmophore in a form 
absorbing at 403 nm (presumably 2). The same treatment of reduced la 
resulted in no release of chromophore. Treatment with sodium hydroxide 
of reduced la did not release 2. This is in agreement with the 
observation of Morino et al. (1974) that reduction fixes the chromophore 
to the protein. Heat denaturation of the native enzyme under the same 
Figure 13. Reaction of g sub form of cytosolic aspartate aminotransferase 
with L-serine-O-sulfate 
Solid serine sulfate (final concentration of 12 mM) was added 
to 400 yL of 1.4 X 10"^ M aspartate aminotransferase in 0.04 
M sodium acetate buffer, pH 5.1 at room temperature. (1) 
Absorption spectrum of native enzyme. (2) Spectrum of 
inactivated enzyme (la'), 10 min after addition of serine 
sulfate. (3) Spectrum of inactivated enzyme (lb'), 20 h 
after addition of serine sulfate. (4) Spectrum of 
inactivated enzyme (lb'), treated with sodium borohydride. 
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conditions releases about 50% of the pyridoxal phosphate. Again, as is 
well-known, reduction fixes the coenzyme to the protein. 
Properties of ib 
The absorption spectrum of lb has a maximum at 455 nm whose position 
and intensity are constant from pH 5.4 to 8.3. It is devoid of circular 
dichroism. Dialysis against water or against 0.1 M acetate buffer, pH 
5.4, or 0.1 M triethanolamine HCl buffer, pH 8.3, with or without 
addition of 0.3 mM pyridoxal phosphate causes no reactivation of the 
enzyme. Form lb is very stable in 0.06 M acetate buffer at pH 5.4 and 
rapidly forms large orange crystals in the presence of 8% polyethylene 
glycol of molecular weight 4000 (Metzler et al., 1979). However, the 
resulting crystals are not isomorphous with those of the native enzyme 
(A. Arnone, The University of Iowa, Iowa City, lA., private communication). 
Dialysis against either 0.1 M acetate or triethanolamine buffers 
converted lb to Ic. However, as reported by Morino et al. (1974), no 
change in spectrum was seen when lb was dialyzed against 3 M sodium 
A. O *. tuC» w 3 a 
Heating of lb in a boiling water bath releases only about 10% of the 
bound chromophore. However, when lb is heated in 3 M formate at pH 5.4, 
the chromophore is released quantitatively. The released material has an 
absorption maximum at 410 nm at pH 5.4 and its electronic spectrum at 
other pH values suggests that it is 2, Reduction with sodium borohydride 
gives a product with properties appropriate for 4. 
Treatment of lb with either sodium borohydride or sodium cyano-
borohydride shifts the absorption maximum from 455 nm to 361 nm (Figure 
11). As reported by Morino et al. (1974), treatment with 6 M guanidine 
hydrochloride denatures the reduced lb and releases about 80% of the 
chromophobe as a low molecular weight material. This material, which we 
identify as compound 4, is obtained in a purer form if lb is thor­
oughly dialyzed against water and is then heated in a boiling water bath. 
Treatment of lb with 9 mM g-mercaptoethanol or with 16 mM cysteine 
sulfinate slowly (overnight) converted it to products similar to that 
obtained by borohydride reduction with an absorption maximum at 360 nm 
and a negative circular dichroism band at about 365 nm. The conversion 
with 3-mercaptoethanol was only about 50% complete. 
Attempts were made to remove the chromophore from lb by displacement 
with phosphate using the procedure employed for resolving the native 
enzyme of pyridoxamine phosphate (Scardi et al., 1963; Yang & Metz1er, 
1979). Warming at 37 °C with 1 M sodium phosphate at pH 5 did not alter 
the electronic and CD spectra of lb during a 24 h period. 
Properties of form Ic 
The Spectrum of the dialyzed form Ic resembles that of the nacive 
enzyme, the absorption band shifting from 430 nm at low pH to 360 nm at 
high pH (Figure 12). Form Ic is catalytically inactive and is converted 
to 2 when treated with NaOH. Heating of Ic in a boiling water bath also 
appears to produce 2 quantitatively. 
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at a concentration of 0.14 M or less. Reduction of Ic with sodium 
borohydride gives a band absorbing at 360 nm, just as does reduction of 
ib. Upon heat denaturation compound 4 was apparently released. 
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Formation of Yellow Compound 2 From GAD 1 
Likos (1977) showed the formation of the low molecular weight 
compound by treating the inactivated glutamate decarboxylase with base. 
When the pH of a solution of GAD 1 was raised to 11, an intense yellow 
color developed and the peak moved to 420 nm. While compound 1 appears 
to be tightly bound to the protein, the yellow product 2 formed at high 
pH could be removed from the protein readily by ultrafiltration (Likos, 
1977). I found that bringing a suspension of trichloroacetate-
precipitated 1 to pH 11 also resulted in the immediate formation of 2. 
The bright yellow color of 2 appears almost instantaneously when a 
solution of 1 is raised to a pH above 9. However, 2 cannot be separated 
readily from the protein by ultrafiltration unless the pH is raised to 
about 11. Similarly Likos stated (1977) that if trichloroacetic acid is 
added to a solution of 1 that has been raised to pH 11, the protein is 
precipitated but 2 is left in solution. However, if the pH is raised 
only to 9, no 2 is found in the supernatant after addition of 
tion band of 1 was not altered by addition of an excess of sodium 
borohydride or sodium cyanoborohydride at pH 4.5. However, if the pH of 
the borohydride-treated solution was then raised to 11, no compound 2 was 
formed. Compound 2 has been purified partially as described in METHODS. 
Likos also observed that both B-chloroalanine and S-phosphoserine 
react with glutamate decarboxylase to yield inactive enzyme absorbing at 
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336 nm. Addition of base to the product from either of these amino acids 
results in the formation of a compound with spectral and electrophoretic 
properties identical to those of 2 . On the other hand, I found no 
reaction with from 3 to 20 mM DL-a-methylserine-O-sulfate. 
Formation of 2 from Inactivated Aspartate Aminotransferase (Forms la, 
lb, & Ic) 
Products la, lb and Ic led to nearly quantitative release of the 
coenzyme as yellow compound 2 with the treatment of NaOH to raise the pH 
to about 11. 
Properties of 2 
In 1979, Schnackerz et al. reported the synthesis of the product of 
an aldol condensation between pyridoxal phosphate and pyruvate followed 
by dehydration. Its structure (X) is given on p. 34. 
Likos noticed the apparent similarity of this compound with 2 
isolated from glutamate decarboxylase. He synthesized the compound and 
showed that its electronic spectrum was identical to that of 2. Its NMR 
and obtained on a 90 MHz spectrometer shown in his Ph.D. dissertation 
(Likos, 1977). He found a close resemblance between these two NMR. 
spectra; however, because of the lack of sensitivity available when the 
spectrum of isolated 2 was taken a number of details were unclear. The 
studies using synthetic 2 described here have been carried out in 
collaboration with Likos. I independently obtained the NMR spectra of 
isolated samples of 2 from glutamate decarboxylase and aspartate 
aminotransferase using a 300 MHz spectrometer. The NMR spectra of 2 
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isolated from the enzymes are compared with that of synthetic 2. 
Electronic spectra have also been compared. 
Electronic Spectra Study of the absorption spsctrus of synthetic 
2 versus pH showed the existence of 3 ionic forms separated by pK 
values of 3.90 and 8.76 (Figure 14, Tables IV & V). The absorption 
spectra of 2 isolated from glutamate decarboxylase is also shown in 
Figure 14. The change in spectrum with pH indicated the existence of 
three spectrally distinct ionic forms separated by pK values of 4.0 and 
8.7 (Table V). Peak positions of individual ionic forms are listed in 
Table IV. The pK values and light absorption spectral properties of 
isolated and synthetic 2 were in satisfactory agreement. 
NMR Spectra Proton and carbon 13 NMR spectra of synthetic 2 are 
shown in Figures 15 & 16. The chemical shifts are summarized in Tables 
VI & VII. The proton NMR spectrum of synthetic 2 at low pH is striking 
(Figure 15a). The sharp resonances of the 6-H (8.30 ppm) and Z'-CHg 
protons (2.72 ppm) and the doublet at 5.09 ppm representing the 5'-CH2 
split by phosphorous are anticipated for the proposed structure. For 
example, the corresponding positions for pyridoxamine phosphate are 8,30, 
2.73, and 5.12 ppm (doublet) respectively (Table VIII). The pair of 
coupled doublets at 7.79 and 7.35 ppm must represent the 4' and B 
protons. The coupling constant of 16.6 Hz observed for synthetic 2 shows 
uhâL Cîié configuration abouC Che 4'—3 C—C bond is trafts. 
Besides the major species of 2 there is a second form present at low 
pH as is indicated by the coupled doublets at 7.03 and 6.67 ppm (Figure 
15a). These have a coupling constant of 16.1 Rz. Integration of 
Figure 14. Absorption spectra of individual ionic species of the keto acid 2 
A. Compound isolated from reaction of glutamate decarboxylase with serine sulfate (data 
taken from Likos, 1977). 
B. Synthetic compound. (1, low pH form; 2, neutral pH form; 3, high pH form). 
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Table IV 
Peak Positions in Electronic Absorption Spectra 
Band maxima in nanometers^ 
Compound Cat ionic ring Dipolar ionic ring Anionic ring 
2 (GAD) 325(shoulder) 411 426 
282 289 296 
(Literature)^ 412 
292 
245 
3 283 313 295 
4 294 342 308 
5 286 311 295 
6 293 342 308 
^Evaluated by computer-assisted fitting with lognormal curves 
Harris et al. (1976). 
^Schnackerz et al. (1979). 
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Table V 
Values of pK Determined Spectrophotometrically 
Compound pK values at 25° 
2 synthetic 3.93^ 8.70& 
2 from glutamate decarboxylase 3.93^ 8.74^ 
(duplicate titrations) 3.98 8.69 
3 synthetic 3.68® 4.69® 8.95® 
from glutamate decarboxylase 4.26^ 9.86^ 
4 reduction product from synthetic 3 
4.4d,b 
5 synthetic 4.77® 9.17® 
from aspartate aminotransferase 4.8^ 9.3^ 
6 from aspartate aminotransferase 5.15^ 9.66^ 
®R. Feldhaus, unpublished results. Private communication, 
Iowa State University. Ames, Iowa. 
bj. Likos (1977). 
^Rapid titration. Subsequent slow changes in spectrum occur, 
presumably as a result of an enol-keto equilibrium. 
^Estimated from titration curves but without computer-assisted 
evaluat ion. 
Figure 15. Proton NMR spectra of synthetic 2 obtained on a 300 MHz spectrometer 
About 2 mg of synthetic '.I was used 
a. pi) = 2.5, 259 scans at 24 °C. 
b. pi) = 7.2, 322 scans at 24 °C. 
c. pi) = 12.5, 509 scans at 40 °C. 
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Figure 16. Natural, abundance carbon-13 NMR spectra of synthetic 2 obtained on a 75.5 MHz 
spectrometer at 24 "C 
About 1.0 mg of synthetic 1 was used. 
a. pD " 1.9, 199707 scans. 
b. pD - 7.1, 88172 scans. 
c. pD =: 12.4, 192900 scans. 
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Table VI 
Chemical Shifts of Resonances in Proton NMR Spectra 
Compound 2 pD 2.48& pD 7.2 pD 12.4(40*0) 
ppm relative ppm relative ppm relative 
area area area 
2'-CH3 Ketone 2.72 3.32 2.49 3.25 2.28 3.66 
Hydrate 2.68 1.04 
4'-H Ketone 7.82 0.95 7.80 1.15 7.92 (1.00) 
7.76 7.75 7.87 
J=16.6 Hz J=16.1 Hz J=16.1 Hz 
Hydrate 7.06 0.29 
7.01 
J=16.1 Hz 
5'-H Ketone 5.10 2.20 5.00 2.28 4.78 2.34 
5.08 4.97 4.76 
J=7.8 Hz J=5.0 Hz J-4.4 Hz 
Hydrate 5.06 0.71 
5 
J=7.8 Hz 
6-H Ketone 8.30 (1.00) 7.64 (1.00) 7.51^ 2.13= 
Hydrate 8.27 0.30 
g-H Ketone 7.38 0.92 7.72 0.82 7.57 
7.33 7.67 7.5lb 
J=16.6 Hz J=i6.1 Hz 
Hydrate 6.70 0.28 
6.65 
J-16.1 Hz 
^The ratio of ketone: hydrate is 3.26: 1 at 24 °C. 
"Overlapped. 
C6H + BB. 
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Table VII 
Nctiiral Ab'.'v.dance Carbon-13 NMR Spectra for Compound 2 
pD 1 .94 
Chemical shift in ppm 
pD 7.08 pD 12.4 
Ketone Hydrate (Hydrat 
ratio) 
ion 
C-2 143.2 142.3 (2.0) 145.4 152.4 
C-3 151.1 150.2 (2.0) 163.2 163.0 
C-4 139.3 138.7 (3.5) 130.9 124.7 
C-5a 133.7 
J=7.6 Hz 
133.3 
J=9.2 
(—) 
Hz 
134.3 
J=7.6 Hz 
130.9 
J=9.2 Hz 
C-6b 130.1 130.2 (2.6) 128.1 130.1 
C-2'c 14.3 14.1 (2.2) 14.8 18.4 
C-4'd 135.7 136.6 (2.7) 140.2 144.4 
C-5'a,e 61.3 
J=4.6 Hz 
-
(--) 61.2 
J=4.6 Hz 
61.6 
J=4.6 Hz 
COOH 165.8 172.5 (1.9) 171-1 172.0 
C(a) 188.7 91.7 (2.7) 197.1 198.0 
C(B)f 131.9 121.7 (3.3) 120.3 124.4 
^Doublets arising from adjacent 
^Doublet in gated proton decoupled spectrum, ^J(CH) = 167 Hz. 
^Quartet in gated proton decoupled spectrum, ^J(CH) = 130 Hz. 
-Triplet in gated proton decoupled spectrum, ~J(CK) = 158 Hz. 
^Triplet in gated proton decoupled spectrum, ^J(CH) = 147 Hz. 
^Doublet in gated proton decoupled spectrum, ^ J(CH) = 189 Hz. 
Table VIII 
Chemical shifts for piroton and carbon-13 NMR spectra of pyridoxamine 
5'-phosphate and pyridoxal 5'-phosphate^ 
Compound Position Chemical shifts (ppm, downfield from tetraraethylsilane) 
Proton Carbon 
PMP pH 2_, 0 pH 6-7 pH 12^ pH 1. 6^ pH 7 pH 12.5^ 
2 144.5 146.0 151.1 
2» 2.73 2.46 2.24 16.3 16.4 20.3 
3 154.7 163.7 161.2 
4 138.2 134.0 137.5 
4" 4.45 4.30 3.70 36.1 37.6 37.6 
5 136.4 135.8 132.2 
5.13 4.93 4.69 
5" 5.10 4.30 4.67 63.0 62.9 63.8 
J = 7.8Hz J = 7.3Hz J = 4.4Hz 
6 8.30 7.66 7.48 132.9 125.1 134.1 
pH 2.6 
Proton 
pH 6-7 pH 12 pH l.od 
Carbon 
pH 6.2C pH 12.4c 
2 144.0 152.4 157.5 
2' 2,66 2.35 2.27 13.7 17.1 20.1 
3 151.5 164.7 168.4 
4 137.0 127.0 125.2 
(aid) 10.50 10.28 10.29 193.8 197.3 197.7 
4' (hyd) 6.55 6.17 6.21 86.9 88.9 — 
5 132.8 136.7 133.8 
5.15 5.05 4.97 
5' 5,12 5.02 4.95 60.9 63.1 63.6 
J = 7.3Hz J = 6.35Hz J = 4.9Hz 
6 8.23 7.57 7.57 129.4 125.9 129.4 
^Unless indicated otherwise, data were collected on a Bruker WM300 NMR spectrometer at 24 
°C. The data an: in satisfactory agreement with those reported by Korytnyk and Ahrens (1970), 
Mantsch and Smith (1979) and Harruff and Jenkins (1976). This table is prepared for 
"Transaminases", Metz 1er and Christen (1983). 
^Temperature = 40 °C. At 24 the HDD peak overlaps the 5' doublet. 
^Data of Mantsch and Smith (1979). 
^Values for hydrate except as indicated for 4'-carbon. 
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the 4'-H and 3-H doublets indicates a ratio of the major form to this 
minor form of 3.3 to 1. Resonances for the 6, 2', and 5' protons of the 
minor form are also present and in the sazs ratio (Table VI). The zost 
obvious possibility is that the minor form is the covalent hydrate of 2 
and that the hydration is at the carbonyl group. This interpretation is 
supported by the NMR spectrum of synthetic 2 (Figure 16a) where the 
resonance for the hydrated carbonyl is seen clearly at 91.7 ppm. Again 
the relative area of the two peaks indicate a hydration ratio of 2.7:1. 
This value is less reliable than that from the proton NMR. Resonances of 
the hydrate are also seen for the other carbon atoms with the exception 
of 5 and 5' (Table VII), Hydration ratios estimated from these varied 
between 1.9 (COO") and 3.5 (C-4). The NMR spectra of 2 at neutral and 
alkaline pH values (Figures 15b, c, 16b,& c. Tables VI & VII) are also 
consistent with the assigned structure but there is no evidence for any 
hydrate at these pH values. 
The reliability of the hydration ratio given by NMR spectroscopy can 
be checked by comparison with the hydration ratios of pyridoxal 
5'-phosphate obtained from both proton NMR spectra and electronic spectra 
(Table IX). Reasonable agreement is seen between the two methods, 
especially at low pH. 
Proton NMR spectra of 2 isolated from both glutamate decarboxylase 
(Figure 17, Table X) and aspartate aminotransferase (Figure IS, Table X) 
were also obtained. Spectra from three separate preparations of 2 
(Figure 18) showed different degrees of contamination. Compound 2 shown 
in Figure 18a was prepared using insufficiently washed Dowex 50 
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Table IX 
Hydration Ratio of Pyridoxal 5'-phosphate 
Comparison between nmr and electronic spectra 
Hydration Ratio 
nmr spectra^ electronic spectra^ 
pH < 1 4,15c _ 4.4d 
pH ~ 2 3.se 3.2 
pH~6.8 0.2f - 0.3g 0.5 
pH> 12 O.Olf - 0.04% 0.09 
^Measured with the Bruker WM300 WB spectrometer at room 
temperature. 1-10 mg of pyridoxal phosphate was dissolved in about 1 mL 
of D2O. The pD value was adjusted by the addition of DCl or NaOD. 
^Data taken from Harris et al. (1976). 
^Averaged data from 2', 5', & 6 protons (3.7 - 4.7). 
'^Averaged data from 2 ' ,  5 ' ,  &  6  protons (3.55 - 4.9). 
^Averaged data from 2', 4', & 5' protons (3.2 - 4.45). 
^Taken from 4'- proton. 
STaken from 6- proton. 
^Taken from 2'- proton. 
Figure 17. Proton NMR spectrum of 2 isolated from glutamate decarboxylase obtained on a 300 MHz 
spectrometer at 24 °C 
About 10 pmol of compound 2 was used at pD = 3.4, 236 scans. 
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Table X 
Comparison of Chemical Shifts^ of 2 isolated from 
GAD and AAT with synthetic 2 
GAD 
9 ,7 umo 1 
pD=2.36 
AAT 
3.0 umol 
pD=1.21 
Synthetic 
10.6 Pmol 
pD=2.48 
2'-CH3 Ketone 2.71 2.72 
Hydrate 2.68 (23%) 2.69 (28%) 
2.72 
2.68 (24%) 
Hydrate 
7.81 J=16.6 Hz 
7.75 
7.06 
7.00 
J=16.1 Hz 
7.84 
7.78 
7.07 
7.02 
J—16.6 Hz 
J=16.1 Hz 
(30%) 
7.82 J=16.6 Hz 
7.76 
7.06 J=16.1 Hz 
7.01 (23%) 
5'-H Ketone 5.10 J=7.8 Hz 3.11 J=7.8 Hz 5.10 J=7.8 Hz 
5.07 5.08 5.08 
Hydrate 5.06 J=7.8 Hz 5.07 J=7.8 Hz 5.06 J=7.8 Hz 
5.04 (31%) 5.04 (37%) 5.04 (24%) 
6'-H Ketone 8.30 8.31 8.30 
Hydrate 8.27 (23%) 8.28 (29%) 8.27 (23%) 
e-H Ketone 7.36 J=16.6 Hz 7.42 J=16.6 Hz 7.38 J=16.6 Hz 
7.30 7.37 7.33 
Hydrate 6.70 J=16.6 Hz 6.71 J=16.6 Hz 6.70 J=16.1 Hz 
6.65 (19%) 6.65 6.65 (23%) 
^Chemical shifts are all relative to tetramethylsilane. 
Figure 18. Proton NMR spectra of 2 isolated from aspartate aminotransferase obtained on a 300 MHz 
spectrometer at 24 °C 
a. About 4 pmol of 2 passed through Dowex 50 (H"*" form) resin which was improperly 
washed (303 scans). 
b. About 3 jjmol of 2 passed through SP-Sephadex form) (310 scans). 
c. About 2 pmol of 2 passed through Dowex 50 (H"*" form) resin which was washed 
thoroughly (236 scans). 
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resin. It is obvious that the aromatic region (6.8-8.5 ppm) is highly 
contaminated with impurities from the Dowex resin. Preparation of 2 
using SP-Sephadex gave a cleaner spectrum at this region, however, more 
contamination was observed at 3.5-4 ppm (Figure 18b). The impurities are 
probably sugar residues hydrolyzed off by base from the Sephadex gel. 
When carefully washed Dowex resin was used, the cleanest spectrum was 
obtained (Figure 18c). The aromatic region is expanded to show the 
detail of the coupling pattern (Figure 19). Each pair of doublets show 
an identical coupling of 16.6 Hz. Irradiation experiments showed that 
there is no interaction between two sets of coupled peaks (Figure 20) 
suggesting that each set belongs to a different species. 
The proton nmr spectra of 2 isolated from glutamate decarboxylase 
and aspartate aminotransferase are compared with that of synthetic 2 in 
Figure 21 and Table X. The identity of the three spectra is evidence 
that 2 from three different systems are the same. 
High voltage electrophoresis The electrophoretic mobilities of 
2 isolated from AAT and GAD and of synthetic 2 were compared with those 
of the reference compounds: pyridoxal phosphate, pyridoxamine phosphate, 
pyridoxal, and pyridoxamine. Likos showed at 4 different pH values (pH 
3.3-10) that 2 isolated from glutamate decarboxylase migrated further 
toward the anode than did pyridoxal phosphate (Likos, 1977). I found 
that mixtures of any combination of 2 from glutamate decarboxylase, 
aspartate aminotransferase, or synthetic migrated as single spots at pH 
6.5. 
Figure 19. Proton NMR spectrum of 2 isolated from aspartate aminotransferase obtained on a 300 MHz 
spectrometer at 24 °C 
Aromatic region (6-8.5 ppm) is expanded (102 scans). 
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Figure 20. Proton NMR spectra of 2 isolated from aspartate aminotransferase obtained on a 300 MHz 
spectrometer 
A. Upfield doublets (7.47 ppm) corresponding to g-proton of keto acid of 2 was 
irradiated (arrow) (125 scans). 
B. Downfield doublets (7.05 ppm) corresponding to the 4'-proton of hydrated 2 were 
irradiated (arrow) (234 scans). 
C. No irradiation (246 scans). 
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Figure 21. Proton NMR spectra of 2 obtained on a 300 MHz 
spectrometer at low pH at 24 °C 
A. Compound isolated from glutamate decarboxylase. 
B. Compound isolated from aspartate aminotransferase. 
C. Synthetic compound. 
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Hydrolysis of 2 to pyridoxal phosphate Likos (1977) observed 
that when compound 2 was heated for 4 h at 110 °C at pH 12.5-13 it 
appeared to be reconverted to pyridoxal phosphate almost quantitatively 
as judged by three criteria. The absorption spectra at pH 1.7, 7.3, and 
9.5 were almost the same as those of pyridoxal phosphate. The migration 
on electrophoresis at four values of pH was also the same as that of 
pyridoxal phosphate. The incubation of apo-aspartate aminotransferase 
with an excess of hydrolyzed 2 gave enzymatic activity. This last 
experiment, however, was not quantitative. Therefore, I carried out a 
quantitative assay of apo-aspartate aminotransferase with the hydrolysis 
product of 2 (Figure 22). Known amounts of pyridoxal phosphate incubated 
with apo-aspartate aminotransferase gave a standard assay curve. From 
this curve, the concentration of pyridoxal phosphate in the hydrolysis 
product of 2 was calculated. The amount of pyridoxal phosphate found in 
the hydrolysis product of 2 was 2.8 nmol, and that from untreated 2 was 
0.9 nmol (Table XI). These values corresponded to 88% conversion from 
2 to pyridoxal phosphate by basic hydrolysis. 
Likos demonstrated the dephosphorylation of compound 2 by alkaline 
phosphatase (1977). The dephosphorylated material (3) was further 
reduced by sodium borohydride to (5). I have studied these compounds 
further and have also investigated the reduced product (4) which retains 
the phosphate group as well as its dephosphorylated derivative (6). 
Schemes XII & XIII summarize the formation of 2 and of its derivatives as 
applied to glutamate decarboxylase and aspartate aminotransferase, 
respectively. 
Figure 22. Identification of base-hydrolyzed product of 2 as pyridoxal phosphate using 
apoasîpartate aminotransJ.'erase 
Reconstitution experiment: of apoaspartate aminotransferase and pyridoxal phosphate. 
Each assay contained 7.0 nraol of apoaspartate aminotransferase. Total amount of 
aspartate transferase actiivity (Mmol/min) per assay tube is plotted versus the amount 
of added pyridoxal phosphate per tube. The values obtained from alkali-treated and 
untreated 2 (3.2 nniol) cire indicated. 
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Table XI 
Assay of aspartate aminotransferase with alkaline hydrolysis product of 2 
Total activity per 
per assay tube 
U mol/min 
The amount of PLP 
found per tube 
nmol 
Concentration of PLP 
M 
Untreated 2 ^  2.9 0.9 1.8 X 10-5 
(28%) 
Alkali-treated 2 10.1 2 . 8  5.6 X 10-5 
(88%) 
^Compound 2 was prepared as A/^gOnm ~ 0.54 at pH 6.7. e " 8,500 cm"^ was assumed. 
Concentration was 6.4 x 10-5 and 3.2 nmol was used for each assay. 
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The characterization of these derivatives of 2 provides additional 
chemical information concerning the structure of 2. 
Properties of 3 
When alkaline phosphatase from E. coli acted upon 2, a marked change 
in spectrum occurred over a time period of about 13 h. The band at 413 
nm was sharply decreased vrtiile an increased absorption was seen at 310 
nm. For the cationic, neutral, and anionic forms, respectively, strong 
bands appeared at 284, 313, and 297 nm. These are 7 to 12 nm lower than 
the positions for pyridoxine. It was noticed that the relative heights 
of the lower energy absorption bands (413 nm region) were much reduced 
relative to these in the high energy region (286-312 nm) compared to the 
spectrum of 2. The spectra were those of a 3-hydroxypyridine ring 
lacking a conjugated exocyclic double bond. A possible explanation was 
the 5'-hydroxyl group added to the double bond in a reaction comparable 
to the cyclization of pyridoxal to the hemiacetal. 
I monitored the reaction of 2 with alkaline phosphatase by TLC and 
high voltage electrophoresis. Treatment of 2 for a short time (5 min) 
with alkaline phosphatase was carried out. The electronic spectrum was 
still almost like that of 2 (Figure 23). The migration of the product 
obtained from a short incubation (5 min) on TLC was the same as that of 
the overnight product (Rf = 0.03). However, the following differences 
were observed. A blue fluorescence was observed for the 5 min product on 
TLC, while the overnight product gave a yellowish-green fluorescence. On 
high voltage electrophoresis, however, the migration of 5 min product did 
Figure 23. Reaction of 2 isolated from aspartate aminotransferase with 
E. coli alkaline phosphatase 
The numbers give the time in minutes after addition of 
alkaline phosphatase (about 0.03 mg). The pH was 8 adjusted 
with IN HCl at 24 °C. 
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differ from that of overnight product. A spot of mobility relative to 
PLP of about 0.85 appeared at pH 6.5 for the 5 min product; a spot of 
mobility relative to PL? of 0.65 was seen for the overnight product. The 
probable route of conversion frcm 2 to 3 by alkaline phosphatase is shown 
in Scheme XIV. Since under the same condition dephosphorylation of PLP 
was completed within 10 min, the formation of Xllly may be very fast and 
the 5 min incubation product appears to correspond to this ring-open 
form. Conversion from the enol form (XIV^) to the ketone (XlVj) is 
believed to be the rate limiting (R. Feldhaus, Iowa State University, 
unpublished results). 
NMR spectra The NMR spectrum of 3 at pD = 6.9 supports the 
proposed structure of XIV(Figure 24, Table XII). The spectra of 3 
isolated from aspartate aminotransferase are also shown (Figure 25). 
Mass spectrum The mass spectrum of 3 shows a parent ion peak at m/e = 
237 (C11H11NO5) while the base peak is at m/e = 149 (CgHyN02) (Figure 26) 
Properies of 4 
hydride gives the identical reduction product, which is designated 4. 
NMR spectra NMR spectra of synthetic 4 and of 4 derivatized from 
2 isolated from aspartate aminotransferase are shown in Figures 27 & 
28. Compound 4 was also prepared by using sodium borodeuteride (Figure 
29). The chemical shifts of 4 are summarized in Tables XIII & XIV. The 
unique NMR properties of 4 are sets of doublets at 0 = 5,03, 5.13, 6.70, 
and 6.86 ppm. The most up-field doublet represents the 5'-protons which 
are split by phosphorous (J = 7.8 Hz). The most down-field doublet (J = 
16,6 Hz) is coupled with a neighboring doublet of doublet (J = 16.1 Hz & 
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Figure 24. Proton NMR spectrum of synthet ic 3 obtained on a 300 MHz spectrometer at 24 °C 
About 10 mg of synthetic 3 at pD = 6.9 was used (384 scans). 
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Table XII 
Proton NMR Spectrum of Synthetic Compound 3 at pD = 6.91 
Protons Chemical Shift 
Z'-CH] 2.46 
4'-H 5.79 
5.07 
5'-CH2 5.11 
5.16 
5.20 
6-H 7.55 
e-H 4.75* 
^Partially exchanged for 
Figure 2.5. Proton NMR spectra of 3 isolated from aspartate aminotransferase obtained on a 300 MHz 
spectrometer at 24 °C 
About 1 pmol of isolated 3 which had undergone gel filtration on a BioGel P2 column was 
used. 
a. pD = 2 (1414 scans). 
b. pD = 8.4 (2314 scans). 
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Figure 26. Mass spectrum of synthetic 3 
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temperature of the probe was quickly raised to 250 °C to 
obtain the stable parent ion peak. 
Figure 27. Proton NMR spectra of synthetic 4 obtained on a 300 MHz spectrometer at 24 °C 
About 10 liraol of synthetic 4 was used. 
a. pD = 2.2 (66 scans). 
b. pD = 6.95 (101 scans) at 40 °C, 
c. pD = 12.95 (100 scans) at 50 °C. 
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Figure 28. Proton NMR spectrum of 4 isolated from aspartate aminotransferase obtained on a 300 MHz 
spectrometer at 24 °C 
Compound 4 (about 1 Umol) was prepared by reducing 2 isolated from aspartate 
aminotransferase with NaBH^ (pD = 1, 363 scans). 
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Figure 29. Proton NMR spectrum of synthetic 4 obtained on a 300 MHz spectrometer at 24 °C 
Synthetic 4 with one deuterium atom incorporated in the «-position (about 16 Wmol) was 
prepared at pD = 2 (201 scans). 
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Table XIII 
Chemical Shif:(;s^ from ^H-NMR Spectrum of Compound 4 
Protons Deuteratejb Undeuterated compound 
4 
PD = 1 PD = 2.2 PD = 6.9 PD = 12.9(50°C) 
2'-CH3 2.67 2.66 2.45 2,21 
4'-H 6.86 J=16.lHz 6.84 J=17.6Hz 6.73 J=16.1Hz 6.70 J=15.1Hz 
6.91 6.89 6.83 6.75 
5'-CH2 5.03 J=7.3Hz 5.01 J=7.8Hz 4.89 J=6.3Hz 4.67 J=4.4Hz 
5.05 5.04 4.91 4.68 
6-H 8.25 8.23 7.73 7.53 
oc-H 5.12 J=5.4Hz 4.57 J=6.8Hz 
5.13 4.60 
3-H 6.68 6.67 J=5.4Hz 6.67 J=5.4Hz 6.30 J=6.8Hz 
J=16.6Hz 6.68 6.69 6.33 
6.74 6.72 J=4.9Hz 6.72 J=5.4Hz 6.36 J=6.8Hz 
6.74 6.74 6.38 
^At 25°C. Chemical shifts in ppm relative to TMS as an external standard. 
bone atom of incorporated at: C-a by reduction of 2 with sodium borodeuteride. 
150 
Table XIV 
Proton NMR Spectrum of Compound 4 Isolated from Boiled Reduced lb 
Protons 
isolated 
4a 
PD = 1 PD = 3.7(50°C) 
4 prepared 
isolated 
PD = 2 
from 
2 
2'-CH3 2.67 2.59 2.63 
4'-H 6.86 
6.91 
J= 16.1Hz 6.72 
6.78 
J=17.lHz 6.80 
-b-
5'-CH2 5.04 
5.07 
J=7,8Hz 4.95 
4.98 
J=7.8Hz 4.98 
5.00 
J=7.3Hz 
6'-H 8.25 8.15 8.20 
a-H 5.13 
5.15 
J=5.4Hz 4.80 
4.81 
J=4.4Hz 5.08 
5.10 
J=3.9Hz 
P-H 6.by 
— 
J=4.yHz b .5b -b-
6.74 J=4.9Hz 6.62 J=4.9Hz -b~ 
6.76 6.63 
^Digital resolution = 0.5Hz, about 5 Pmol for each sample. 
^Insufficient sensitivity to allow accurate determination of 
chemical shifts. 
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J = 5.4 Hz). The former represents the 4'-proton and the latter 
represents the otr-proton which is coupled further with a more upfield 
single proton at S = 5.13 ppm (J = 5.4 Kz) at pD = 2,2 (Figure 27a). 
This single proton at 5 = 5.13 ppm must be the a-proton of 4. The 
spectrum of 4 prepared by reduction of 2 with sodium borodeuteride lacks 
the a-proton peak and the associated coupling with 3-proton (Figure 28). 
As mentioned in the preceding paragraph, 4 is also produced by heat 
treatment of reduced ib. The NMR spectrum of the released compound is 
shown in Figure 30. This compound is indistinguishable from 4 by three 
criteria: (a) NMR; Of special importance is the pair of coupled 
resonances with J = 16.1-16.6 Hz representing the 4' and B protons of 
4. It is evident that 4 exists as the major product and shows an 
extremely clean spectrum in the aromatic region. (b) Electrophoresis. 
High voltage electrophoresis of 4 was performed at 2000 V for 30 min (pH 
6.5). A single spot migrating 5.9 cm toward anode has a closely similar 
migration to that of PLP. A mixture of isolated and synthetic 4 migrated 
as a single spot at pH 6,5. None of the sainple of ^ gave a positive 
result against ninhydrin spray test. (c) Spectra. The absorption 
spectrum of 4 is rather complex. There appear to be absorption bands at 
292 nm (acidic), 342 nm (neutral), and 328 nm (basic pH). 
Properties of 5 
Reduction of 3 with either sodium borohydride or sodium 
cyanoborohydride at neutral pH led to loss of the low energy absorption 
bands. A strong band remained at 284 nm at pH 2.2, 312 nm at pH 8.3, and 
298 nm at pH 12.0. Spectra of 5 isolated from glutamate decarboxylase. 
Figure 30. Proton NMR spectra of 4 isolated from lb after its reduction with sodium borohydride 
and heat denaturation obtained on a 300 MHz spectrometer at 24 °C 
a. About 5 yraol of compound was prepared at pD = 0.9 (4125 scans). 
b. At pD = 3.7 (152 scans). 
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aspartate aminotransferase, and of synthetic 5 are all identical (Figure 
31, Table IV). 
The mass spectrum of synthetic 5 shows a parent ion peak at m/e = 
239 (CiiHigNO^) (Figure 32). The base peak at m/e = 164 (CgH^gNC^) 
results from a loss of [CO2H-CHOH]•*•. The fragmentation patterns of 
synthetic 3 (Figure 26) and 5 are similar, a fact that supports the 
existence of a cyclic structure in both compounds. 
Compound 5 reacts only weakly with Gibbs reagent. Migration of 5 
on high voltage electrophoresis at 2000 V, pH 6.5, for 30 min was 2.8 cm 
toward anode, about half of that of PLP. 
NMR spectra The nmr spectra of synthetic 5 are simple 
(Figures 33 & 34) and are described in Table XV. The expected eleven 
carbon atoms are present. Some of the resonances are doubled in a manner 
indicative of the presence of a diastereomeric pair (Table XV). However, 
the crystalline synthetic 5 was clearly a single diastereomer. Complete 
assignments have been made and are consistent with the cyclic structure 
shown (Scheme XIII). Of particular importance is the fact that in gated 
proton decoupled spectra the 5' carbon appeared as a triplet with ^J(CH)~ 
50 Hz and the 4' carbon as a doublet with -J(CK) ~ 146 Hz (Figure 34, 
Table XV). This suggests that two hydrogen atoms are bonded to C-5' and 
only one to C-4' in accord with the proposed cyclic structure. The 
proton NMR spectrum is more complex but is also in agreement with the 
proposed structure (Figure 35, Table XVI). The ^H-NMR spectra of 5 
isolated from aspartate aminotransferase are shown in Figure 36 (Table 
XVI). The quality of these spectra is not excellent because of line 
Figure 31. Absorption spectra of 5 
A. Isolated from glutamate decarboxylase (1, pH = 1.2; 2, pH 
= 6.6; 3, pH = 11.0), 
B. Isolated from aspartate aminotransferase (1, pH = 2.5; 2, 
pH = 8,1; 3, pH = 11.1), 
C. Synthetic (1, low pH form; 2, neutral pH form; 3, high pH 
form; spectrum was recorded by R. Feldhaus). 
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Figure 32. Mass spectrum of synthetic 5 
The electron-impact mass spectrum was obtained at 20 eV. The 
probe was quickly heated to 250 °C to obtain a stable parent 
ion peak. 
Figure 33. Carbon-13 NïîR spectra of synthetic 5 obtained on a 75.5 MHz spectrometer at 24 °C 
Broad band proton decoupled spectra were recorded using about 10 mg of synthetic 5 in 2 
mL of OyO. 
a. pD = 1,6 (17472 scans) 
b. pD = 4,5 (46871 scans) 
c. pD = 7,7 (27827 scans) 
d. pD = 13.0 (40538 scan») 
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Figure 34. Carbon-13 NMR spectra of synthetic 5 obtained on a 75.5 MHz spectrometer at 24 °C 
Gated proton decoupled spectra were recorded using about 10 mg of synthetic 5 in 1)2®' 
a. pD = 1.6 (34425 scans). 
b. pD = 7.7 (38232 scans). 
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Table XV 
Natural Abundance NMR Spectra for Synthetic Compound 5 
Chemical shift in ppm 
pD = 1.2-1.6 4.51 7.71 13.0 
C-2 144.9 
144.83 
143.6 143.2 148.0 
C-3 147.2 149.3 156.7 155.4 
C-4 142.3 142.6 142.6 136.0 
C-5 137.3 137.1 135.5 133.4 
C-6b 125.1 122.8 117.3 124.3 
C-2'c 13.5 13.5 14.0 17.4 
C-4'd 66.6 68.0 69.1 69.5 
C-5'e 69.7 
69.63 
69.2 69.4 69.6 
COOH 176.6 179.4 180.6 181.0 
C-a ^ 78.9 
78.52 
79.3 78.0 80.1 
c-g S 35.4 
35.03 
36.8 36.9 37.9 
^Additional peaks observed in mixture of diastereoisomers. 
^Doublet in gated proton decoupled spectrum, ^J(CH) = 191 Hz. 
CQuartet in gated proton decoupled spectrum, ^J(CH) = 131 Hz. 
(^Doublet in gated proton decoupled spectrum, ^J(CH) = 146 Hz. 
^Triplet in gated proton decoupled spectrum, -J(CH) = 150 Hz. 
^Doublet in gated proton decoupled spectrum, ^J(CH) = 154 Hz. 
^Triplet in gated proton decoupled spectrum, ^J(CH) = 131 Hz. 
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broadening. One probable cause is that the sample contains 
diastereomers. The chemical shifts of these diastereomers may differ 
slightly which would cause such broadening. The ^H-NMR spectrum of 
deuterated 5 is shown in Figure 37. The lack of the a-proton around 4-5 
ppm is evident. 
It is interesting to note that the electronic spectrum of 5 closely 
resembles that of isopyridoxal in all three states of protonation of the 
ring (Table XVIII). Although the proton NMR spectra of isopyridoxal 
(Figure 38, Table XVIII) are not identical with those of 5 (Figure 35, 
Table XVI), the cyclic structure of both 5 and of isopyridoxal is evident 
from these•spectra. The two 5'-CH2 protons are no longer equivalent and 
appear as a pair of doublets (J = 12 Hz for 5 and J = 15.6 Hz for 
isopyridoxal). The peaks of the lower doublet centered at 5.06 ppm for 
5 (5.3-5.4 ppm for isopyridoxal) are split further (J ~ 2 Hz) by long 
range coupling, probably to 4'-H. The 4'-proton of 5 appears as a pair 
of doublets (J ~ 2 Hz) centered at 4.47 ppm and caused by coupling to the 
two nonequivalenC p-proCons. The latter appears as two multiplets 
centered at 1.94 and 2.12 ppm. The a-proton forms two doublets at 4.13 
ppm with J~ 2.4 Hz. 
Properties of 6 
The electronic spectrum of 6 is identical to that of 4. The 
absorption bands are at 289 nm (low pH), at 342 nm (neutral), and at 322 
nm (high pH). Two pK values, 5.2 and 9.5, were estimated. Neither 4 nor 
6 show any evidence of the cyclic structure proposed for 3 and 5. 
Figure 35. Proton NMR spectra of synthetic 5 obtained on a 300 MHz spectrometer at 24 °C 
a. About 5 mg of synthetic 5 at pD = 1.5 was used (1060 scans). 
b. pD = 12.5 (10 scans). 
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Table XVI 
Chemical shifts of proton NHR spectra of 5 
Synthetic 5 
pD 1.5 pD 12.5 
5 isolated from 
aminotrans ferase 
pD 2 pD 5 
aspartate 
pD 10.5 
2'-CH3 2.63 2.25 2.71 2.68 2.33 
4'-H 5.74 5.42 
J = 7.3 Hz J = 7.8 Hz 
5.87 5.50 
5'-H 5.25 5.00 
J = 13.0 Hz J = 12.2 Hz 
5.31 5.27 5.10 
6—H 8.11 7.43 8.17 7.96 7.53 
a-H 4.47 4.14 
J = 4.4 Hz J = 2 Hz 
J = 11 Hz 
4.59 4.21 
g-H 2.33a 2.03b 2.57 — 2.02 
^Multiplet, J ~3.5 Hz. 
t)-*#.. "I s. ^ 1 ^ lu T I'lUXC J.C U 9 O 6. 1&6. 
Figure 36. Proton NMR spectra of 5 isolated from aspartate aminotransferase obtained on a 300 MHz 
spectrometer at 24 °C 
Compound 5 was purified through DEAE-Sephadex column (eluted with ammonium bicarbonate 
buffer gradient) and BioGel P2 column (eluted with 0.02 M acetic acid) prior to nmr 
measurements. 
a. About 10 jjmol of 5 at pD = 2 was used (4463 scans). 
b. About 1 limol of 5 at pD = 5 was used. 
c. About 1 pmol of 5 at pD = 10.5 was used (189 scans). 
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Figure 37. Proton NMR spectrum of synthetic 5 obtained on a 300 MHz spectrometer at 24 °C 
One deuterium atom was incorporated into the a-position of synthetic 5 with NaBD^ at pD 
= 2 (643 scans). 
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Table XVII 
Comparison of Absorption Spectra^ of 5 and Isopyridoxal 
Form AAT 5 b 
Position 
nm 
Synthet­
ic 5 c 
IsoPL^ AAT 5 
Width 
cm-1 X 10-3 
Synthet­
ic 5 
IsoPL AAT 5 
Skevmes s 
Synthet­
ic Î» 
IsoPL 
Cat ionic 286 35.24 35.35 3.24 3.39 3.39 1.45 1.42 1.50 
Neutral 313 32.17 32.18 3.73 3.48 3.40 1.56 1.46 1.50 
Anionic 298 33.85 34.08 3.65 3.40 3.64 1.45 1.47 1.52 
^All values are given after computer-assisted fitting with log normal curves. 
^Absorption upectra are obtained at three different pH values. 
^Recording of spectra and fitting with log normal curves were taken by R. Feldhaus. 
^Taken from library of absorption spectra in this laboratory. Calculated pK values are 4.14, 
8.60, and 12.31. 
Figure 38. Proton NMR spectra o£ isopyridoxal obtained on a 300 MHz spectrometer at 24 °C 
About 2 mg of isopyridoxal was used. 
a. pD = 2.5 (36 scans); 
b. pD = 6.8 (56 scans); 
c. pD = 12.5 (167 scans). 
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Table XVIII 
Proton NMR Chemical Shifts of Isopyridoxal® 
2.48 
pD 
6.81 11.91 
2' -H 2.69 2.51 2.35 
4 '-H 5.25 J 
5.30 
5.39 
5.44 
= 2 Hz 5.09 
5.14 
5.24 
5.29 
5.02 
5 '-H 6.71 6.62 6.71 
6' -H 8.31 7.77 7.65 
®About 10 mg was dissolved into D2O and used for this purpose. 
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Loss of the ketone at the a-position in 4 and 6 would presumably make the 
cyclization unfavorable. 
Chemical Modification of Model Coapounds 
Compound 2 isolated from both glutamate decarboxylase and aspartate 
aminotransferase have been submitted for mass spectrometry as a solid. 
Likos first attempted this approach and found an ion peak at 207 for 
compound 2 isolated from glutamate decarboxylase (unpublished results). 
There were no peaks above 207. Later I reproduced his observation, then 
found that the 207 peak originated from the oil of the vacuum pump in the 
system. Thus, I learned that 2 was not a good compound to study by mass 
spectometry because of its poor volatility. I started to develop the 
chemical modification techniques such as acetylation, 
trimethylsilylation, trifluoroacetylation, or permethylation for use with 
vitamin B6 compounds. Thus, 1 could apply the technique to the compounds 
isolated from the enzymes. Since those modifications are known to make 
the nonvolatile compounds volatile and give good mass spectra. Among the 
zodel compounds used are pyridoxine. pyridoxamine, reduced Schiff bases 
of pyridoxal with alanine, isopropylamine and ethanolamine, and a 
dipeptide (Leu-Ala). The reduced Schiff bases with pyridoxal were 
prepared in crystalline forms, and their functional groups were modified 
with common techniques mentioned above. Permethylation first described 
by Hakomori (1964) in use of methylsulrinyl carbariiori in dimethyl 
sulfoxide showed the most promising results which are described in the 
following sections. 
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Pyridoxine Both proton and carbon-13 NMR spectra (Figure 39) 
show that methylation occurs at the 3'-, 4'-, and 5*-positions of 
pyridoxine. The GC-MS spectrum of this derivative showed the expected 
parent ion peak at 211 (CiiHiyNOg, Figure 40). 
Pyridoxamine The methylation procedure employed here tends to 
give quaternary ammonium salt at 4'-position of pyridoxamine. To avoid 
this problem, pyridoxamine was acetylated first using acetic anhydride in 
methanol. In this way, acetylation occurs only upon the amino group. 
The GC-MS spectrum of the permethylated product of pyridoxamine shows a 
parent ion peak at 252 which is expected for C13H20N2O3 (Figure 41). 
Reduced alanine-pyridoxal Schiff base The crystalline reduced 
alanine-pyridoxal Schiff base was of sufficient purity according to the 
both proton and carbon-13 NMR spectra (Figure 42). Its GC—MS spectrum 
indicates a parent ion peak at 296 (C15H24N2O4, Figure 43). Reduced 
Schiff base with one deuterium atom incorporated in its 4'-position was 
also synthesized in crystalline form. Its NMR spectra, both proton and 
carbon-13. indicated a pure preparation (Figure 44). The GC-MS spectrum 
of the methylation product of this deuterated Schiff base has peaks of 
one mass increment (m/e = 29 7) over (Figure 45) those of its undeuterated 
derivative (m/e = 296). 
Reduced isopropylamine-pyridoxal Schiff base The absorption 
spectrum of crystalliiic reduced isopropylamine-pyridoxal Schiff basa 
gives absorption bands at 296 nm (acidic), at 321 nm (neutral) and at 309 
Figure 39. NMl spectra of methylated product of pyridoxine 
a. Pi'oton nmr spectrum obtained on a 60 MHz spectrometer. About 10 mg of derivative 
Wcis dissolved in CDCI3. 
b. The carbon-13 nmr spectrum obtained on a 22.5 MHz spectrometer. 
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Figure 40. GC-MS spectrum of the methylated product from pyridoxine 
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Figure 41. GC-MS spectrum of permethylated acetylated pyridoxamine 
Figure 42. NMR spectra of the reduced alanine-pyridoxal Schiff base 
a. Proton NMR spectrum obtained on a 60 MHz spectrometer. Crystalline compound (10 
mg) was dissolved in D2O. 
b. Carbon-13 NMR spectrum obtained on a 22,5 MHz spectrometer. 
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Figure 43. The GC-MS spectrum of the methylated product of the reduced 
alanine-pyridoxal Schiff base 
Figure 44. NMR fipectra of reduced cil.anine-pyridoxal Schiff base with one deuterium atom 
incorporated into the 4'-position 
a. Proton NMR spectrum obtained on a 90 MHz spectrometer. About 10 mg of compound was 
dissolved in D2O. 
b. Carbon-13 NMR spectra obtained on a 22.5 MHz spectrometer. Broadband proton 
decoupling was performed (15876 scans). 
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Figure 45. The GC-MS spectrum of the methylated product of the reduced 
alanine-pyridoxal Schiff base with one deuterium atom 
incorporated into the 4'-position 
Ionization voltage 20 eV was employed. 
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nm (basic) (Figure 46). The GC-MS spectrum of this compound indicates a 
parent ion peak at 252 which corresponds to C14H24N2O2 (Figure 47). 
Reduced ethanolamine-pyridoxal Schiff base The crystalline 
reduced ethanolamine-pyridoxal Schiff base exhibits an absorption maximum 
at 295 nm (pH = 1.28), at 326 nm (pH = 6.58) and at 309 nm (pH = 10.05) 
(Figure 48). The GC-MS spectrum of the methylation product of this 
reduced ethanolamine-pyridoxal Schiff base gives a parent ion peak at 268 
corresponding to an experimental formula of C14H24N2O2 (Figure 49). 
Permethylation of the dipeptide (Leu-Ala) The use of the mass 
spectrometer to identify small peptide attracts me in various ways. If 
a compound which I have isolated from enzyme systems contains a small 
peptide, identification of this peptide using a mass spectrometer may be 
helpful. Also, instead of running an amino acid analyzer to identify a 
residue X which might modify the coenzyme moiety, mass spectroscopy could 
be used. It might have some advantages over the use of amino acid 
analysis. 
The GC-MS spectrum of the permethylated dipeptide of Leu-Ala shows a 
parent ion peak at 286 suggesting C14H26N2O4 (Figure 50). 
Figure 46. Absorption spectrum of the reduced i s opr opy1amin e-pyr ido xa1 
Schiff base 
1, pH =1; 2, pH = 6; 3, pH = 12 
202 
_L 
22 26 30 
W A V E  N U M B E R  
I  I  I  
34, .38 (  C M  '  X  i c r )  
I 
550 500 450 400 
W A V E  
350 300 
L E N G T H  ( N M  )  
250 
203 
mo-
.N-CH3 
50.0-
CH. 
L y 
CMH24N2O2 =252 
56 65 77 
III It III 
40 
tl/E 50 
72 
93 IÇ8 
88 
I nil t I 
120 
179 
164 
150 
136 
' I ' " ' !"  ' I—'—I——'—I—'—r 
150 
191 
237 
T 
7792. 
22 
L_r-4 
2(20 
I ' I 
258 
Figure 47. The GC-MS spectrum of the methylated product of the reduced 
iso-propylamine-pyridoxal Schiff base 
Figure 48. Absorption spectrum of the reduced ethanolamine-pyridoxal 
Schiff base 
1, pH = 1.3; 2, pH = 6.6; 3, pH = 10.1 
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Figure 50. GC-MS spectrum of the permethylated product of the dipeptide, 
Leu-Ala 
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DISCUSSION 
A key step of many proposals for mechanism-based inactivation of 
pyridoxal phosphate-dependent enzymes is a nucleophilic attack of a 
residue X of the enzyme on the 3-carbon of an a, g-unsaturated Schiff 
base such as a-aminoacrylate (Scheme XV). This has been accepted in 
general without any real proof. The results given in this dissertation 
show that the above assumption is wrong for both bacterial glutamate 
decarboxylase and for cytosolic aspartate aminotransferase of pig heart. 
A key finding was the observation that a yellow compound 2 is 
released by NaOH from both glutamate decarboxylase (Likos & Metzler, 
1976) and from aspartate aminotransferase inhibited by either L-serine-
0-sulfate, g-chloroalanine or phosphoserine. This compound was 
identified by Likos (Monsanto Co., St. Louis, MO., private communication) 
as a known compound that had been synthesized by Schnackerz et al. (1979) 
through an aldol condensation between pyruvate and pyridoxal phosphate 
(Scheme X). Results presented in this dissertation verify this identity, 
show that the same compound is produced from aspartate aminotransferase 
and provide a detailed description of molecular properties. 
Both synthetic and isolated 2 have been examined by NnR and Light 
absorption spectroscopy, thin layer chromatography and high voltage 
electrophoresis. The proton NMR spectrum of synthetic 2 is compared with 
that of 2 isolated from glutamate decarboxylase and from aspartate 
aminotransferase in Figure 21 and Table X. Over the pD range of 1.2-2.5, 
all three spectra agree within 0.07 ppra. None of the results raises any 
doubt of the identity of 2. The complete assignments of 
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chemical shifts of proton and carbon-13 NMR spectra (TablesVI, VII, X) 
confirm the structure of synthetic 2 as reported by Schnackerz et al. 
(1979; see Scheme XVI). 
Compound 2, both synthetic and isolated, has been converted by 
dephosphorylation and reduction to a series of derivatives 3—6. Their 
structures and the identities of synthetic and isolated compounds are 
also established (Scheme XVI). 
Compound 2 exists in two interconvertible forms at low pH (Figure 
19). These are presumed to be the keto acid form and its covalent 
hydrate. The hydration ratio [hydrate]/[carbonyl] at pH 1.5 is about 
0.30 for 2 ,but is about 3.2 for pyridoxal phosphate (Harris et al., 
1976). This difference is not surprising as aldehydes are usually more 
hydrated than ketones. The hydration ratio for pyridoxal phosphate drops 
to 0.5 in the neutral form and to 0.09 in the anion (Harris et al., 
1976). It is understandable, therefore, that for 2 at neutral or basic 
pH, there is no detectable hydration as judged by the NMR spectrum. 
The pK values of 2 (3,98; 8,69) are both just 0,36 higher than for 
pyridoxal phosphate, but are still less than those of pyridoxine (5.00, 
8.97). Thus, the electron-withdrawing effect of the carbonyl group 
in 2 is less than that in pyridoxal phosphate but is still clearly 
evident. Note that the pK of the phosphate group has not been estimated 
because dissociation of that group has very little effect on the 
absorption spectrum. 
Formation of 2 from both inactivated bacterial glutamate 
decarboxylase and from aspartate aminotransferase with serine sulfate 
H 
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Scheme XVI. 
treated with base suggests the new mechanism proposed in Scheme XVII. The 
formation of free aminoacrylate by the enzyme and the attack by the 
latter upon the 4'-carbon atom of the Schiff base are strongly 
indicated. Since 2 is synthesized by the aldol condensation of pyridoxal 
phosphate and pyruvate, analogous chemistry can occur in the active site 
of the enzyme. However, it is clear that most of the aminoacrylate 
formed is released and does not react with the Schiff base, since over 
100 molecules of pyruvate and ammonia are produced before the enzyme is 
inactivated (Wang & Walsh, 1978; John & Fasella, 1969; Soper & Manning, 
1978). The first structure shows Or-aminoacrylate Schiff base 
intermediate (XVIIg). XVII^ can go through "transimination" to release 
free aminoacrylate and to form internal Schiff base (XVII^). This step 
is reverse of the formation of external Schiff base with substrate. The 
carboxyl group of the aminoacrylate is bound to its binding site 
interacting with Arg-386 (AAT) and the eliminated sulfate presumably 
occupies the site of its initial binding on Arg*-292 (AAT) of other 
subunit. Til 18 binding of c^-carboxyl group of free aminoacrylate allows a 
simple rotation through its C^-COO~ bond, which makes it possible that 
its S-carbon is ready for nucleophilic attack on carbon 4' of the 
coenzyme. It is a well-known fact that both the nitrogen and the 
B-carbon of enamines such as aminoacrylate have nucleophilic properties 
(Dyke, 1973). Protonation of the g-carbon during above process is 
probably the most favorable and produces pyruvate and amsonis 
spontaneously. The nucleophilic attack of 3-carbon onto carbon 4' of the 
coenzyme is crucial in order to have a covalent adduct which produces 
213 
J Ir-
®0DC^iNH2 ®ooc^ / 
•"tV"® . I N 
H C^N-^ TRANSIMINATION ^ C^N 3 
H 
XVHo XVllb 
OOC^O 
H_C^^N pH s n 
Re leased INACTIVE 
3 3  6  nm 
NttBH 
®00Cv^MH2 
..\.® Jr-H'^OH 
MgM 
H,C^N 
No Release 
pH - 1S 
Scheme XVII. XVI'L 
214 
2 with base. The resulting adduct is proposed as the structure of 1 
from glutamate decarboxylase and la from aspartate aminotransferase. It 
is likely that the coenzyme tilts forward toward the substrate during the 
addition as it does during the transimination of normal substrate by 
aspartate aminotransferase (Karpeisky & Ivanov, 1966; Ivanov & Karpeisky, 
1969; Arnone et al., 1982). The formation of 2 from 1 treated with base 
can be explained by the abstraction of the 5-proton followed by the 
elimination of the G-amino group of lysine from the 4'-position of the 
coenzyme. The imino group at the a-position is hydrolyzed off by base to 
give the ketone 2. It is uncertain whether 1 contains the imino group 
as pictured or whether this has been hydrolyzed to a ketone with loss of 
ammonia. Likewise 1 (la for aspartate aminotransferase) might be either 
the imine shown or the ketone. Treatment of 1 with sodium borohydride 
reduces the C=NH bond (or C=0 bond) and decreases the acidity of the 
3-protons. This prevents the removal of the G-proton by attack of 0H~ 
and prevents the formation of 2. The resulting complex (XVII^.) is stable 
and suitable for peptide work. Peptide work done by Morino's group 
(Morino & Okamoto, 1973; Morino & Tanase, 1978) presumably started from 
this complex (XVII^.), and found the Lys-258 as the modified residue. 
Formation of 2 from 1 is quite logical; however, formation of 2 from the 
previously proposed structure (XVg) is quite difficult. Base treatment 
of XVII^ would be expected to yield pyridoxâmine piîospitâtë (FM?) ârid 
possibly 3-hydroxypyruvate (Scheme XVIII). 
Peptide work carried out by John et al. (1973) is of interest. 
Isolated peptide from aspartate aminotransferase reacted with serine 
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sulfate gave the possible sequence of Phe-Ser-(Carboxymethylcysteine, 
Gly)-Asn. The isolated peptide could represent the known active site 
sequence, ?he-Ser-LyS"-Asn. However, the finding of Gly in the isolated 
peptide is confusing. It might be possible that some of a longer peptide 
such as Phe-Ser-Lys*-Asn-Phe-Gly was present in the preparation which 
gave Gly as a part of the sequence. Carboxymethylcysteine might have 
been confused with the modified lysine residue. 
An additional fact supporting the structure of 1 is its chirality. 
Morino and Okamoto (1973) and Morino and Tanase (1978) observed a posi­
tive circular dichroism for tryptic and chymotryptic peptides isolated 
from both 3-chloroalanine-inactivated cytosolic and mitochondrial 
aspartate aminotransferase after reduction. The shortest fragments, 
which were tetrapeptides, retained the same circular dichroism observed 
for the intact inactivated enzyme. It is known that coenzyme having the 
chiral center at 4*-position has more influence to the circular 
dichroism. It is more attractive to propose the structure of 1 than that 
f  ^  î  oH  (  WTTT ,  )  .  q im ra  Ï  sc  o  r *  o -n t *  o - r»  o» -
4'-position. It is of interest that the circular dichroism of 
&-chloro-alanine-inactivated alanine aminotransferase is negative (Morino 
et al., 1979), a fact that may indicate the opposite chirality on 
4'-position of the derivative analogous to 1 formed with that enzyme. 
A puzzling aspect of the reaction of glutamate decarboxylase with 
serine sulfate is the finding of an (S-carboxyl group in the structure of 
2 . Glutamate decarboxylase apparently abstracts the oi-proton from the 
Schiff base of serine sulfate with the coenzyme rather than catalyzing 
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decarboxylation. Perhaps the presence of the sulfate group in place of 
the carboxylate of the normal substrate leads to a distortion of the 
Schiff base conformation that makes removal of the o-proton more likely 
than decarboxylation. Since the enzyme is also inactivated by g-chloro-
alanine or phosphoserine in a similar manner and releases 2 with base 
treatment, this explanation is not totally satisfactory. It is 
interesting to recall that mammalian glutamate decarboxylase abstracts an 
Qfproton from the mechanism-based inactivator, (S)-4-aminohex-5-ynoic 
acid (Jung et al., 1980). Jung et al. speculated that mammalian enzyme 
is capable of removing an ot-proton from the substrate as do trans­
aminases, while the bacterial enzyme cannot. However, in the light of 
the reactions of serine sulfate, &-chloroalanine and phosphoserine, with 
the bacterial enzyme, abstraction of the ot-proton by bacterial enzyme 
cannot be explained by the above theory given by Jung et al. 
Yet another puzzle is the role of the protein factor. It is not 
clear whether the protein factor is involved in the normal catalysis of 
bacterial glutamate decarboxylase. It is unlikely that the protein 
factor is a subunit of glutamate decarboxylase. However, the protein 
factor may be a protein which forms a complex with the enzyme, inhibits 
the release of ct-aminoacrylate, and makes the inactivation event more 
probable. Or another explanation is that it forms a complex with the 
enzyme distorting its active site conformation and allowing the removal 
of the ct-proton from serine sulfate to initiate the inactivation. 
Of special interest for aspartate aminotransferase is the slow 
formation of the product lb which absorbs at 455 nm. This appears to 
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be identical to the product formed from &-chloroalanine in the presence 
of 3.5 M formate (Morino et al., 1974) and may be closely related to a 
product A-Onned slowly by &.hs action oA. 3~chlcrcalaiixne on alanxme 
aminotransferase (Golichowski & Jenkins, 1978). When lb is treated with 
sodium borohydride, the resulting reduced coenzyme derivative is released 
by heating as compound 4. This is quite analogous to findings by Morino 
et al. (1974) that 80% of label was lost from chloroalanine-
inactivated enzymes (either cytosolic or mitochondrial) after reduction 
with KBH4 and following denaturation by 6 M guanidine HCl. On this basis 
it is proposed that lb is the keto acid 2 bound at the active site 
(Scheme XIX). The imino group that is pictured in this scheme as present 
in la must be lost by hydrolysis either prior to or immediately after 
elimination of the Lys-258 side chain from la. Since g-protons 
immediately next to the imino or keto group of la should bequite acidic, 
a slow removal of one of these protons and elimination of the amino group 
of Lys-258 from the 4'-position are quite reasonable. The release 
of 2 by heating ib prepared in 3 H formate strongly suggest the existence 
of 2 at the active site. The release of 2 is also observed when lb is 
treated with base. Compound 2 must be very tightly bound to the active 
site in lb probably through ionic interactions. Heat treatment 
of lb does not release a significant amount of chromophore. However, 
reduced ib releases compound 4 quantitatively by heat treatment. The 
identification of released chromophore as 4 was carried out as follows. 
The proton NMR spectrum of the released chromophore was compared with 
that of 4 isolated from aspartate aminotransferase and synthetic 4 
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(Table XIV). The striking similarity of these NMR spectra identifies the 
released chromophore as 4. Further evidence is provided by the identical 
electronic spectra at all pK values and the identical migrations on paper 
electrophoresis. Electrophoresis provided an additional intersting 
conclusion: the released chromophore has a hydroxyl group at 
a-position. The imino nitrogen of la, which is pictured in Scheme XIX, 
must be lost sometime before the formation of lb. Otherwise the released 
chromophore should have carried an NHg* group at the ct-position. 
The nature of form Ic is not clear. Borohydride reduction does not 
fix the coenzyme to the protein. Therefore, Ic cannot be a Schiff base 
of 2 with Lys-258. It seems possible that the sulfate eliminated from 
the inhibitor remains bound in the active site in lb, or is replaced by 
formate. Form Ic may have lost this sulfate and have undergone a change 
in protein conformation which allows the observed pH dependent change in 
absorption spectrum. It seems reasonable that the 430 nm band at low pH 
could be caused by 2 if the double-bond containing side chain were 
heat or base releases 2, it is evident that Ic has 2 in its active site. 
Three absorption bands at 333, 375, and 420 nm which were observed by 
Morino et al. (1974) in the reaction of aspartate aminotransferase with 
B-chloroalanine in the absence of formate correspond to those of Ic. 
Compound Ic exhibits a peak around 370 nm at high pK; however, it is 
hard to see how a simple deprotonation could shift the band to a shorter 
wavelenth at high pH. A possible explanation is that at high pH some 
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nucleophile adds to the carbonyl group of the bound 2. This could be 
Lys-258 forming a carbinolamine rather than a Schiff base. The band at 
333-335 nm observed in ic is interpreted as some remaining form ia. 
Since the slow conversion from la to lb is suspected of never being 
complete, it is reasonable to see residual amount of la in Ic. 
Both bacterial glutamate decarboxylase and cytosolic aspartate 
aminotransferase are inactivated in a similar manner by aminoacrylate 
generated in the active site discussed above (see Scheme XVII). A 
question of obvious interest is to what extent similar mechanism apply to 
other mechanism-based inactivation reactions. A strong similarity is 
expected in the reaction of mitochondrial aspartate aminotransferase and 
alanine aminotransferase with g-chloroalanine. In the case of the 
reaction, L-aspartate-S-decarboxylase with 3-chloroalanine a considerably 
different chemistry is suggested (Tate et al., 1969; Relyea, et al., 
1974). Relyea et al. (1974) found the ^^C-labeled peptide as 
3-hydroxypyruvate through ester linkage to a glutamic acid residue at the 
active site of the snzyzs. 
The action of vinylglycine, a known mechanism-based inactivator for 
aspartate aminotransferase, can be explained by an alternative chemistry 
related to that described here (Scheme XX). An inactivated form (XX^ or 
XXg) analogous to 1 or la of serine sulfate is suggested. As Gehring et 
al. (1977b) and Rando (1974b) observed, an absorption maximum at 335 nm 
corresponding to the inactivated enzyme by vinylglycine shares the same 
absorption position with that of serine sulfate inactivated enzyme. 
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The only structural change between the active intermediate forms of the 
inhibitors is a methyl group at B-position of carbon-3. This change 
presumably affects the reactivity against base. No formation of a 
compound similar to 2 with base was reported by Gehring et al. for the 
vinylglycine complex; instead, pyridoxal phosphate is released. This 
seems contrary to our suggestions; however, 2 is very unstable in strong 
base and is converted to pyridoxal phosphate. Therefore, it is still 
possible that the 335 nm form is an adduct (XXj or XXg) which is 
analogous to la. 
Recently Cooper et al. (1982) reported the mechanism-based 
inactivation of cytosolic aspartate aminotransferase with 3-methylene-
DL-aspartic acid (111^ or XXIg). Interestingly the appearance of a new 
peak at 335 nm for the inactivated enzyme is same as for serine sulfate-
inactivated aspartate aminotransferase. Therefore, it is likely that our 
mechanism applies for this inactivator (Scheme XXI). In the final 
structure (XXIg), which is proposed by using our mechanism, formation of 
2 with base would be impossible because of the absence of a S-proton, 
However, like vinylglycine it may be able to release pyridoxal phosphate, 
but not pyridoxamine phosphate. Contrary to the author's expectation, 
Cooper et al. (1982) mentioned formation of pyridoxamine phosphate by 
deproteinization of the inactivated enzyme. Pyridoxamine phosphate was 
judged by electrophoresis. Rando et al. observed the same result using 
2-amino-4-methoxy-3-butenoic acid (1976). In both cases, the description 
of the quantity of pyridoxamine phosphate released was poor. 
Additionally, neither enzyme was inactivated 100%. Thus it still may be 
possible that a 1 type structure exists in this case. Since residual 
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substrate-Schiff base may well produce pyridoxamine phosphate as a minor 
product. 
Manning et al. (1958) reported the a, g-eli=ination reaction of 
cytosolic aspartate aminotransferase of pig heart with B-chloroglutamic 
acid. The authors did not observe the inactivation of the enzyme. 
Possible intermediate (XXIly) which possesses an a, g-unsaturated bond 
is proposed by Manning et al. Similar intermediate is also proposed by 
Rando (1974b) and Gehring et al. (1977), and Cooper et al. (1982) for the 
mechanism-based inactivation of aspartate aminotransferase with 
vinylglycine and g-methyleneaspartate, respectively. Intermediate (see 
Vjj) is quite analogous to that of g-chloroglutamate (XXIIy). If an 
accepted mechanism which employs a Michael addition of group X to the 
g-carbon is applied, intermediate form (XXIly) should be converted into 
the inactivated form (XXII^). This step should be common for these 
inactivators; serine sulfate, g-chloroalanine, vinylglycine, g-methy1-
eneaspartate, and g-chloroglutamate. Only chloroglutamate, however, 
does not inactivate the enzyme. An obvious question is asked why 
chloroglutamate is the exception. Manning et al. (1968) simply stated 
the reason as enzyme specificity. A more likely explanation can be given 
from our findings. The proposed mechanism employed here requires: 1) 
transimination reaction, 2) formation of free aminoacrylate, 3) rotation 
around C£—carboxylate group, then 4) attack of p—carbon atom of amino­
acrylate onto 4'-carbon of the coenzyme. In the case of chloroglutamate, 
the first two categories can be satisfied; however, the third category 
may not be met. Since two carboxylase groups of chloroglutamate fit into 
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their own binding sites in which they interact with Arg-386 and Arg*-292, 
respectively, the rotation around a-carboxylate group may be 
prohibited. Because of this restriction of rotation, the attack of 6-
carbon atom upon 4'-carbon of the coenzyme ring is unfavorable. This 
explanation seems to be quite reasonable; however, two mechanism-based 
inactivators do not fit this explanation. These are B-fluorooxalo-
acetate and g-methyleneaspartate. The latter has already been 
discussed. The former is known to be a suicide substrate for 
mitochondrial aspartate aminotransferase (Kun et al., 1960). These two 
inactivators possess two carboxylate groups which are believed to 
interact with same arginine residues in the enzyme as shown above. The 
difference between these inactivators and chloroalanine is the length of 
the carbon chain. In general, longer chain hydrocarbon is believed to 
have more flexibility than shorter chain one. If this is applied here, 4 
carbon substrate should have more restriction of rotation than the 5 
carbon substrate, chloroglutamate. This seems to be somehow 
contradictory to our proposal. However, if the K< values for these 
mechanism-based inactivators are taken into account a more satisfactory 
explanation is obtained. Table XIX shows K£ values for some of the 
inactivators. Chloroglutamate shows high Kg value ( >150 mM); however, 
meChyleneaspartate has extremely small value (3 mM). In general, the 
K£ value indicates the binding ability of the molecule to its target 
enzyme, methyleneaspartate is expected to stay at the active site longer 
than chloroglutamate. Since we propose free aminoacrylate generated in 
the active site as the form that inactivates the enzyme, the 
Table XIX 
List of K£ values of mechanism-based inactivatoro for 
aspartate aminotransferase 
Me ch an i sm- bas ed 
inhibitors 
"Possible structure 
for intermediate?" 
Inact ivat ion Ki (mM) 
Serine sulfate 
p-Chloroalanine 
Phosphoserine 
Vinylglycine 
p-methyleneaspartiîte 
OOC-
-ooc^ 
P L p  
" O O C y ^ C O O  
yes 
yes 
yes 
70a 
20 0^ 
3C 
p-Chloroglut amate 
OOC. c o o  
&The value foi: serine sulfate (John & Fasella, 1969). 
^The value for chloroalanine (Morino et al., 1974). 
•^Kg value for chloroglutamate (Manning et al., 1968). 
no >150<i 
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mechanism-based inactivator which shows stronger affinity for the enzyme 
is expected to be more effective for inactivation. Therefore, the action 
of chloroalanins car. be explained by both restriction of its rotation and 
its poor binding ability to aspartate aminotransferase. It has been 
known that 4-carbon substrates are generally better substrate than 5-
carbon substrates for aspartate aminotransferase (Ivanov, 1973). Thus, 
the above explanation is not surprising. Some research groups reported a 
protective effect of thiol reagents, and others did not see the 
protection during suicide inactivation. Manning and Soper (1978) and 
Cavallini et al. (1973) are among the former, and Silverman and Levy 
(1980) and Cooper et al. (1982) the latter. An explanation similar to 
the above satisfies the observations. Inactivators having high are 
trapped easier by thiol reagents than these having low K^. If one talks 
about this in terms of turnover number/inactivation ratio, probably, the 
inactivators having a high ratio will be trapped by thiol reagents during 
inactivation more efficiently than these having a low ratio. In the case 
of aspartate aminotransferase, inactivators whose K; values are above 70 
mM (e.g. serine sulfate) are expected to be trapped by a thiol reagent 
and those below 10 mM (e.g. g-methyleneaspartate) are not. 
Gamma-aminobutyrate aminotransferase of brain is inhibited by 
ethanolamine-O-sulfate (John & Fowler, 1976; Fowler & John, 1981). The 
inactivated enzyme has an absorption band at 330 fia but the 415 aù band 
of the native enzyme is only partially gone. This suggests that the 
chemistry of Scheme XVII might be correct for this enzyme. The ketimine 
product could be in equilibrium with some aldimine which may exhibit a 
230 
nm band. On the other hand the 415 nm band of the inhibited enzyme could 
resemble product lb of the present study. The enzyme is also inhibited 
by 4-amino-5-halopentenoic acids (Silverman & Levy, 1980, 1981). The 
changes in absorption spectrum are very similar to those observed with 
ethanolamine-O-sulfate. 
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SUMMARY 
The mechanism-based inactivation of both glutamate decarboxylase 
(GAD) of coli (Sukhareva & Braunstein, 1971) and of cytosolic 
aspartate aminotransferase (AAT) by L-serine-O-sulfate (John & Fasella, 
1969) has been reinvestigated. The 336 nm form of GAD (1) releases a low 
molecular weight yellow compound 2 at high pH (Likos & Metz1er, 1976). 
The identical compound is released from AAT. Compound 2 is a known 
compound which had been synthesized previously (Schnackerz et al. 1979) 
by an aldol condensation between pyridoxal phosphate (PLP) and pyruvate-
The identity of 2 was recognized by Likos (Monsanto Co., private 
communication). The characterization of 2 isolated from GAD and AAT and 
comparison with synthetic 2 by 300 MHz NMR spectroscopy is described. 
The structure of 1 is proposed in collaboration with Likos as an adduct 
formed by attack of the g-carbon of a-aminoacrylate on the "internal" 
Schiff base of PLP with a lysine side chain from the protein. 
Aminoacrylate is generated from serine sulfate by an enzyme-catalyzed 
3-elimination. Compound 2 is presumably released by attack of hydroxyl 
ion on the adduct 1. Release is prevented by treatment with NaBH^ which 
is assumed to reduce the C=N or C=0 linkage in 1 and thereby to lower the 
acidity of the B-proton removed in the formation of 2. A new "protein 
factor" was discovered. The protein factor is required for the 
inactivation of GAD. Its partial purification and properties are 
described. The formation of 2 indicates that GAD does not require 
decarboxylation during the inactivation with serine sulfate. As 
described in the reaction with chloroalanine (Morino et al., 1974), AAT 
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is inactivated over a 10 min period and the absorption maximum at pH 5.4 
shifts from 430 nm to 336 nm (la). Upon prolonged standing, the peak 
shifts again over a period of 20 h to 455 nm (lb), a behavior entirely 
similar to that reported by Morino et al. for chloroalanine in the 
presence of 3 M formate. When the 20 h product lb is reduced with NaBH4 
and then heated in a boiling water bath, a material which is identical to 
the reduction product of 2 (4) is released. Therefore, the 20 h 
product lb consists of 2 bound to the enzyme. Pathways for the formation 
of the various compounds are proposed. These findings require a 
réévaluation of the known mechanisms of action of many mechanism-based 
inactivators of PLP-dependent enzymes. 
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